Mechanisms	O
of	O
transactivation	O
by	O
nuclear	B-protein
factor	I-protein
of	I-protein
activated	I-protein
T	I-protein
cells-1	I-protein
.	O

Nuclear	B-protein
factor	I-protein
of	I-protein
activated	I-protein
T	I-protein
cells-family	I-protein
proteins	I-protein
(	O
NFAT1/NFATp	B-protein
,	O
NFATc	B-protein
,	O
NFAT3	B-protein
,	O
and	O
NFAT4/NFATx/NFATc3	B-protein
)	O
play	O
a	O
key	O
role	O
in	O
the	O
transcription	O
of	O
cytokine	B-DNA
genes	I-DNA
and	O
other	O
genes	O
during	O
the	O
immune	O
response	O
.	O

We	O
have	O
defined	O
the	O
mechanisms	O
of	O
transactivation	O
by	O
NFAT1	B-protein
.	O

NFAT1	B-protein
possesses	O
two	O
transactivation	B-DNA
domains	I-DNA
whose	O
sequences	O
are	O
not	O
conserved	O
in	O
the	O
other	O
NFAT-family	B-protein
proteins	I-protein
,	O
and	O
a	O
conserved	O
DNA-binding	B-DNA
domain	I-DNA
that	O
mediates	O
the	O
recruitment	O
of	O
cooperating	O
nuclear	B-protein
transcription	I-protein
factors	I-protein
even	O
when	O
it	O
is	O
expressed	O
in	O
the	O
absence	O
of	O
other	O
regions	O
of	O
the	O
protein	O
.	O

The	O
activity	O
of	O
the	O
NH2-terminal	B-protein
transactivation	I-protein
domain	I-protein
is	O
modulated	O
by	O
an	O
adjacent	O
regulatory	B-protein
region	I-protein
that	O
contains	O
several	O
conserved	B-DNA
sequence	I-DNA
motifs	I-DNA
represented	O
only	O
in	O
the	O
NFAT	B-protein
family	I-protein
.	O

Our	O
results	O
emphasize	O
the	O
multiple	O
levels	O
at	O
which	O
NFAT-dependent	O
transactivation	O
is	O
regulated	O
,	O
and	O
predict	O
significant	O
differences	O
in	O
the	O
architecture	O
of	O
cooperative	O
transcription	B-protein
complexes	I-protein
containing	O
different	O
NFAT-family	B-protein
proteins	I-protein
.	O

Mechanisms	NULL
of	NULL
Transactivation	NULL
by	NULL
Nuclear	NULL
Factor	NULL
of	NULL
Activated	NULL
T	NULL
Cells-1	NULL
By	NULL
Chun	NULL
Luo	NULL
,	NULL
Emmanuel	NULL
Burgeon	NULL
,	NULL
and	NULL
Anjana	NULL
Rao	NULL
From	NULL
the	NULL
Division	NULL
of	NULL
Cellular	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Dana-Farber	NULL
Cancer	NULL
Institute	NULL
and	NULL
Department	NULL
of	NULL
Pathology	NULL
,	NULL
Harvard	NULL
Medical	NULL
School	NULL
,	NULL
Boston	NULL
,	NULL
Massachusetts	NULL
02115	NULL
Summary	NULL
Nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells-family	NULL
proteins	NULL
(	NULL
NFAT1I/NFATp	NULL
,	NULL
NFAT	NULL
'	NULL
c	NULL
,	NULL
NFAT3	NULL
,	NULL
and	NULL
NFATA4/NFATx/NFATc3	NULL
)	NULL
play	NULL
a	NULL
key	NULL
role	NULL
in	NULL
the	NULL
transcription	NULL
of	NULL
cytokine	NULL
genes	NULL
and	NULL
other	NULL
genes	NULL
during	NULL
the	NULL
immune	NULL
response	NULL
.	NULL

We	NULL
have	NULL
defined	NULL
the	NULL
mechanisms	NULL
of	NULL
transactivation	NULL
by	NULL
NFAT1	NULL
.	NULL

NFAT1	NULL
possesses	NULL
two	NULL
transactivation	NULL
domains	NULL
whose	NULL
sequences	NULL
are	NULL
not	NULL
conserved	NULL
in	NULL
the	NULL
other	NULL
NFAT	NULL
-family	NULL
proteins	NULL
,	NULL
and	NULL
a	NULL
conserved	NULL
DNA-binding	NULL
domain	NULL
that	NULL
mediates	NULL
the	NULL
recruitment	NULL
of	NULL
cooperating	NULL
nuclear	NULL
transcription	NULL
factors	NULL
even	NULL
when	NULL
it	NULL
is	NULL
expressed	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
other	NULL
regions	NULL
of	NULL
the	NULL
protein	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
the	NULL
NH-terminal	NULL
transactivation	NULL
domain	NULL
is	NULL
modulated	NULL
by	NULL
an	NULL
adjacent	NULL
regulatory	NULL
region	NULL
that	NULL
contains	NULL
several	NULL
conserved	NULL
sequence	NULL
motifs	NULL
represented	NULL
only	NULL
in	NULL
the	NULL
NFAT	NULL
family	NULL
.	NULL

Our	NULL
results	NULL
emphasize	NULL
the	NULL
multiple	NULL
levels	NULL
at	NULL
which	NULL
NFAT	NULL
-dependent	NULL
transactivation	NULL
is	NULL
regulated	NULL
,	NULL
and	NULL
predict	NULL
significant	NULL
differences	NULL
in	NULL
the	NULL
archi-	NULL
tecture	NULL
of	NULL
cooperative	NULL
transcription	NULL
complexes	NULL
containing	NULL
different	NULL
NFAT	NULL
-family	NULL
proteins	NULL
.	NULL

he	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
(	NULL
NFAT	NULL
)	NULL
!	NULL

is	NULL
a	NULL
calcium-regulated	NULL
transcription	NULL
factor	NULL
that	NULL
is	NULL
a	NULL
major	NULL
target	NULL
for	NULL
the	NULL
immunosuppressive	NULL
drugs	NULL
cyclosporin	NULL
A	NULL
(	NULL
CsA	NULL
)	NULL
and	NULL
FK506	NULL
(	NULL
1-3	NULL
)	NULL
.	NULL

The	NULL
DNA-binding	NULL
specificity	NULL
of	NULL
NFAT	NULL
is	NULL
conferred	NULL
by	NULL
a	NULL
novel	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
,	NULL
of	NULL
which	NULL
four	NULL
members	NULL
(	NULL
NFAT1/NFATp	NULL
,	NULL
NFATc	NULL
,	NULL
NFAT3	NULL
,	NULL
and	NULL
NFATx/NFAT4/NFATc3	NULL
,	NULL
each	NULL
containing	NULL
several	NULL
isoforms	NULL
)	NULL
have	NULL
so	NULL
far	NULL
been	NULL
described	NULL
(	NULL
4-9	NULL
)	NULL
.	NULL

NFAT	NULL
1	NULL
protein	NULL
is	NULL
expressed	NULL
in	NULL
several	NULL
classes	NULL
of	NULL
immune	NULL
system	NULL
cells	NULL
(	NULL
10-12	NULL
)	NULL
,	NULL
consistent	NULL
with	NULL
the	NULL
detection	NULL
of	NULL
nuclear	NULL
NFAT	NULL
DNA-binding	NULL
activity	NULL
in	NULL
activated	NULL
T	NULL
,	NULL
B	NULL
,	NULL
mast	NULL
,	NULL
and	NULL
NK	NULL
cells	NULL
(	NULL
13-19	NULL
)	NULL
.	NULL

The	NULL
distribution	NULL
of	NULL
the	NULL
other	NULL
NFAT	NULL
-family	NULL
proteins	NULL
has	NULL
not	NULL
yet	NULL
been	NULL
assessed	NULL
at	NULL
the	NULL
protein	NULL
level	NULL
;	NULL
however	NULL
the	NULL
mRNAs	NULL
encoding	NULL
these	NULL
proteins	NULL
differ	NULL
in	NULL
their	NULL
cell	NULL
and	NULL
tissue	NULL
distributions	NULL
and	NULL
their	NULL
representation	NULL
in	NULL
resting	NULL
versus	NULL
activated	NULL
cells	NULL
(	NULL
5-7	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
each	NULL
protein	NULL
may	NULL
subserve	NULL
a	NULL
different	NULL
function	NULL
.	NULL

NFATc	NULL
mRNA	NULL
is	NULL
expressed	NULL
at	NULL
high	NULL
levels	NULL
in	NULL
skeletal	NULL
muscle	NULL
and	NULL
in	NULL
activated	NULL
lymphoid	NULL
cells	NULL
,	NULL
NFATx/	NULL
NFAT4	NULL
mRNA	NULL
is	NULL
predominantly	NULL
expressed	NULL
in	NULL
the	NULL
thymus	NULL
,	NULL
and	NULL
NFAT3	NULL
mRNA	NULL
is	NULL
most	NULL
strongly	NULL
expressed	NULL
outside	NULL
the	NULL
immune	NULL
system	NULL
(	NULL
5-7	NULL
)	NULL
.	NULL

An	NULL
important	NULL
component	NULL
of	NULL
transactivation	NULL
by	NULL
NFAT	NULL
family	NULL
proteins	NULL
is	NULL
their	NULL
cooperation	NULL
in	NULL
the	NULL
nucleus	NULL
with	NULL
Fos	NULL
and	NULL
Jun	NULL
(	NULL
20	NULL
,	NULL
21	NULL
)	NULL
.	NULL

This	NULL
cooperation	NULL
is	NULL
mediated	NULL
by	NULL
interac-	NULL
'	NULL
Abbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
CAT	NULL
,	NULL
chloramphenicol	NULL
acetyltransferase	NULL
;	NULL
CsA	NULL
,	NULL
cyclosporin	NULL
A	NULL
;	NULL
DBD	NULL
,	NULL
DNA-binding	NULL
domain	NULL
;	NULL
hGH	NULL
,	NULL
human	NULL
growth	NULL
hormone	NULL
;	NULL
NFAT	NULL
,	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
;	NULL
NHR	NULL
,	NULL
NFAT	NULL
homology	NULL
region	NULL
;	NULL
TAD	NULL
,	NULL
transactivation	NULL
domain	NULL
.	NULL

tion	NULL
of	NULL
the	NULL
highly	NULL
conserved	NULL
DNA-binding	NULL
domains	NULL
(	NULL
DBDs	NULL
)	NULL
of	NULL
NFAT	NULL
-family	NULL
proteins	NULL
with	NULL
Fos-Jun	NULL
and	NULL
Jun-Jun	NULL
dimers	NULL
(	NULL
6	NULL
,	NULL
7	NULL
,	NULL
22	NULL
)	NULL
;	NULL
the	NULL
bZIP	NULL
(	NULL
basic	NULL
region-leucine	NULL
zipper	NULL
)	NULL
regions	NULL
of	NULL
Fos	NULL
and	NULL
Jun	NULL
suffice	NULL
for	NULL
this	NULL
interaction	NULL
(	NULL
21	NULL
)	NULL
,	NULL
although	NULL
an	NULL
acidic	NULL
region	NULL
of	NULL
Fos	NULL
has	NULL
also	NULL
been	NULL
implicated	NULL
(	NULL
23	NULL
)	NULL
.	NULL

Overex-pression	NULL
of	NULL
Fos-	NULL
and	NULL
Jun-family	NULL
proteins	NULL
in	NULL
T	NULL
cells	NULL
greatly	NULL
augments	NULL
transcription	NULL
driven	NULL
by	NULL
tandem	NULL
copies	NULL
of	NULL
the	NULL
IL-2	NULL
and	NULL
IL-4	NULL
promoter	NULL
NFAT	NULL
sites	NULL
in	NULL
activated	NULL
T	NULL
cells	NULL
(	NULL
20	NULL
,	NULL
24-26	NULL
)	NULL
.	NULL

It	NULL
has	NULL
also	NULL
been	NULL
suggested	NULL
that	NULL
NFAT	NULL
-family	NULL
proteins	NULL
are	NULL
able	NULL
to	NULL
act	NULL
independently	NULL
or	NULL
cooperate	NULL
with	NULL
transcription	NULL
factors	NULL
of	NULL
the	NULL
GATA	NULL
family	NULL
(	NULL
18	NULL
,	NULL
27	NULL
)	NULL
.	NULL

We	NULL
asked	NULL
whether	NULL
NFAT	NULL
-family	NULL
proteins	NULL
contain	NULL
intrinsic	NULL
transactivation	NULL
domains	NULL
(	NULL
TADs	NULL
)	NULL
,	NULL
or	NULL
whether	NULL
they	NULL
function	NULL
by	NULL
recruiting	NULL
other	NULL
transcription	NULL
factors	NULL
.	NULL

Here	NULL
we	NULL
define	NULL
the	NULL
mechanisms	NULL
of	NULL
transactivation	NULL
by	NULL
NFAT1	NULL
.	NULL

We	NULL
show	NULL
that	NULL
NFAT1	NULL
contains	NULL
two	NULL
intrinsic	NULL
TADs	NULL
at	NULL
its	NULL
NH	NULL
,	NULL
-	NULL
and	NULL
COOH-terminal	NULL
ends	NULL
that	NULL
are	NULL
not	NULL
represented	NULL
in	NULL
the	NULL
other	NULL
NFAT	NULL
-family	NULL
proteins	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
the	NULL
NH-terminal	NULL
TAD	NULL
is	NULL
regulated	NULL
by	NULL
the	NULL
adjacent	NULL
NFAT	NULL
homology	NULL
region	NULL
(	NULL
NHR	NULL
)	NULL
,	NULL
a	NULL
serine-	NULL
and	NULL
proline-rich	NULL
region	NULL
that	NULL
contains	NULL
several	NULL
sequence	NULL
motifs	NULL
conserved	NULL
within	NULL
the	NULL
NFAT	NULL
family	NULL
.	NULL

We	NULL
also	NULL
show	NULL
that	NULL
the	NULL
conserved	NULL
DBD	NULL
of	NULL
NFAT1	NULL
contributes	NULL
potently	NULL
to	NULL
transactivation	NULL
at	NULL
composite	NULL
NFAT	NULL
sites	NULL
,	NULL
since	NULL
it	NULL
is	NULL
capable	NULL
of	NULL
recruiting	NULL
cooperating	NULL
transcription	NULL
factors	NULL
even	NULL
when	NULL
expressed	NULL
independently	NULL
of	NULL
the	NULL
other	NULL
regions	NULL
of	NULL
NFAT	NULL
1	NULL
.	NULL

Our	NULL
results	NULL
suggest	NULL
that	NULL
NFAT	NULL
dependent	NULL
transactivation	NULL
involves	NULL
a	NULL
common	NULL
mechanism	NULL
mediated	NULL
by	NULL
the	NULL
conserved	NULL
DBD	NULL
,	NULL
as	NULL
well	NULL
as	NULL
unique	NULL
mechanisms	NULL
involving	NULL
the	NULL
nonconserved	NULL
TADs	NULL
.	NULL

141	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

©	NULL
The	NULL
Rockefeller	NULL
University	NULL
Press	NULL
»	NULL
0022-1007/96/07/141/07	NULL
$	NULL
2.00	NULL
Volume	NULL
184	NULL
July	NULL
1996	NULL
141-147	NULL
Materials	NULL
and	NULL
Methods	NULL
Transfections	NULL
.	NULL

-	NULL
Jurkat	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
2-5	NULL
jug	NULL
of	NULL
expression	NULL
and	NULL
reporter	NULL
plasmids	NULL
,	NULL
subdivided	NULL
equally	NULL
into	NULL
identical	NULL
cultures	NULL
,	NULL
incubated	NULL
for	NULL
18-24	NULL
h	NULL
at	NULL
37°C	NULL
,	NULL
and	NULL
then	NULL
stimulated	NULL
overnight	NULL
with	NULL
1	NULL
wM	NULL
ionomycin	NULL
,	NULL
10	NULL
nM	NULL
PMA	NULL
,	NULL
or	NULL
both	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
1	NULL
M	NULL
CsA	NULL
(	NULL
added	NULL
30	NULL
min	NULL
before	NULL
the	NULL
stim-uli	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
18-24	NULL
h	NULL
later	NULL
,	NULL
and	NULL
cell	NULL
extracts	NULL
were	NULL
assayed	NULL
for	NULL
chloramphenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
or	NULL
luciferase	NULL
activity	NULL
as	NULL
described	NULL
(	NULL
8	NULL
)	NULL
.	NULL

When	NULL
the	NULL
percent	NULL
conversion	NULL
of	NULL
CAT	NULL
assay	NULL
was	NULL
either	NULL
very	NULL
high	NULL
or	NULL
very	NULL
low	NULL
,	NULL
the	NULL
assay	NULL
was	NULL
repeated	NULL
with	NULL
an	NULL
adjusted	NULL
amount	NULL
of	NULL
cell	NULL
lysate	NULL
to	NULL
ensure	NULL
a	NULL
linear	NULL
range	NULL
.	NULL

Transfection	NULL
efficiencies	NULL
were	NULL
determined	NULL
by	NULL
measuring	NULL
human	NULL
growth	NULL
hormone	NULL
(	NULL
hGH	NULL
)	NULL
expression	NULL
from	NULL
a	NULL
cotransfected	NULL
RSV-hGH	NULL
plasmid	NULL
(	NULL
0.5	NULL
pg	NULL
)	NULL
,	NULL
and	NULL
protein	NULL
concentration	NULL
was	NULL
determined	NULL
by	NULL
Bradford	NULL
assay	NULL
(	NULL
Bio-Rad	NULL
Laboratories	NULL
,	NULL
Hercules	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

GAL4	NULL
Plasmids	NULL
.	NULL

-	NULL
GAL4-NFAT1	NULL
(	NULL
1-415	NULL
)	NULL
was	NULL
constructed	NULL
by	NULL
replacing	NULL
the	NULL
E2F	NULL
fragment	NULL
of	NULL
GAL4-E2F	NULL
(	NULL
28	NULL
)	NULL
between	NULL
the	NULL
BamHI	NULL
and	NULL
Xbal	NULL
sites	NULL
with	NULL
the	NULL
1,264-bp	NULL
fragment	NULL
of	NULL
human	NULL
NFAT1	NULL
cDNA	NULL
(	NULL
8	NULL
)	NULL
,	NULL
from	NULL
the	NULL
BssHII	NULL
site	NULL
to	NULL
the	NULL
EcoRI	NULL
site	NULL
in	NULL
the	NULL
polylinker	NULL
of	NULL
pBluescript	NULL
.	NULL

It	NULL
encodes	NULL
amino	NULL
acids	NULL
1-415	NULL
of	NULL
NFAT	NULL
1	NULL
in	NULL
frame	NULL
with	NULL
the	NULL
GAL4	NULL
DBD	NULL
(	NULL
amino	NULL
acids	NULL
1-147	NULL
)	NULL
.	NULL

The	NULL
GAL4-NFAT1	NULL
(	NULL
57-415	NULL
)	NULL
,	NULL
GAL4-NFAT1	NULL
(	NULL
145-415	NULL
)	NULL
,	NULL
GAL4-NFAT1	NULL
(	NULL
259-415	NULL
)	NULL
,	NULL
GAL4-NFAT1IASP1	NULL
,	NULL
GAL4-NFAT1ASP2	NULL
,	NULL
and	NULL
GAL4-NFAT1ASS	NULL
plasmids	NULL
were	NULL
made	NULL
by	NULL
excising	NULL
appropriate	NULL
restriction	NULL
fragments	NULL
from	NULL
GAL4-NFAT1	NULL
(	NULL
1-~415	NULL
)	NULL
and	NULL
religating	NULL
the	NULL
plasmids	NULL
.	NULL

The	NULL
COOH	NULL
-terminally	NULL
deleted	NULL
plasmids	NULL
,	NULL
GAL4-NFAT1	NULL
(	NULL
1-293	NULL
)	NULL
,	NULL
GAL4-NFAT1	NULL
(	NULL
1-230	NULL
)	NULL
,	NULL
and	NULL
GAL4-NFAT1	NULL
(	NULL
1-171	NULL
)	NULL
were	NULL
made	NULL
by	NULL
replacing	NULL
the	NULL
BamHI-Xbal	NULL
E2F	NULL
fragment	NULL
from	NULL
GAL4-E2F	NULL
with	NULL
the	NULL
appropriate	NULL
restriction	NULL
fragments	NULL
of	NULL
NFAT1	NULL
.	NULL

The	NULL
chimeras	NULL
encoded	NULL
by	NULL
GAL4-NFAT1	NULL
(	NULL
1-415	NULL
)	NULL
,	NULL
GAL4-NFAT1	NULL
(	NULL
1-293	NULL
)	NULL
,	NULL
GAL4-NFAT1	NULL
(	NULL
1-230	NULL
)	NULL
,	NULL
GAL4-NFAT1	NULL
(	NULL
1-171	NULL
)	NULL
,	NULL
GAL4-NFAT1IASP1	NULL
,	NULL
GAL4-NFAT1ASP2	NULL
,	NULL
and	NULL
GAL4-NFATIASS	NULL
have	NULL
a	NULL
linker	NULL
with	NULL
the	NULL
sequence	NULL
PEFPAGDRIRA	NULL
between	NULL
the	NULL
GAL4	NULL
DBD	NULL
and	NULL
NFAT1	NULL
sequences	NULL
.	NULL

GAL4-NFAT1	NULL
(	NULL
57-415	NULL
)	NULL
has	NULL
a	NULL
linker	NULL
of	NULL
PEFPA	NULL
,	NULL
and	NULL
the	NULL
other	NULL
NH-terminal	NULL
deletions	NULL
have	NULL
a	NULL
linker	NULL
of	NULL
PEFP	NULL
.	NULL

Except	NULL
for	NULL
GAL4-NFAT1	NULL
(	NULL
1-293	NULL
)	NULL
,	NULL
GAL4-NFAT1	NULL
(	NULL
1-230	NULL
)	NULL
,	NULL
and	NULL
GAL4-NFAT1	NULL
(	NULL
1-171	NULL
)	NULL
,	NULL
all	NULL
other	NULL
constructs	NULL
have	NULL
an	NULL
extra	NULL
sequence	NULL
of	NULL
PRAEF	NULL
before	NULL
the	NULL
stop	NULL
codon	NULL
.	NULL

GAL4-NFAT1	NULL
(	NULL
727-927	NULL
)	NULL
was	NULL
constructed	NULL
by	NULL
replacing	NULL
the	NULL
NFAT1	NULL
(	NULL
1-415	NULL
)	NULL
fragment	NULL
between	NULL
the	NULL
Smal	NULL
and	NULL
Xbal	NULL
sites	NULL
in	NULL
GAL4-hNFAT1	NULL
(	NULL
1-415	NULL
)	NULL
with	NULL
the	NULL
Ncol-HindIII	NULL
fragment	NULL
from	NULL
pLGP-mNFATA-C	NULL
(	NULL
8	NULL
)	NULL
.	NULL

It	NULL
has	NULL
a	NULL
linker	NULL
of	NULL
PEFP	NULL
between	NULL
the	NULL
GAL4	NULL
DBD	NULL
and	NULL
the	NULL
murine	NULL
NFAT	NULL
1	NULL
sequence	NULL
.	NULL

GAL4-BB-E2F	NULL
was	NULL
constructed	NULL
by	NULL
replacing	NULL
the	NULL
BamHI-Xbal	NULL
fragment	NULL
of	NULL
GAL4-NFAT1	NULL
(	NULL
57-415	NULL
)	NULL
with	NULL
the	NULL
Xmal-Xbal	NULL
fragment	NULL
of	NULL
E2F	NULL
of	NULL
GAL4-E2F	NULL
.	NULL

It	NULL
has	NULL
a	NULL
linker	NULL
of	NULL
PGI	NULL
between	NULL
NFAT	NULL
1	NULL
{	NULL
amino	NULL
acids	NULL
57-318	NULL
)	NULL
and	NULL
E2F	NULL
.	NULL

The	NULL
GAL4-E2F	NULL
,	NULL
RSV-GAL4DBD	NULL
,	NULL
RSV-CAT	NULL
,	NULL
and	NULL
the	NULL
reporter	NULL
CAT	NULL
plasmid	NULL
with	NULL
three	NULL
GAL4	NULL
DNA-binding	NULL
sites	NULL
(	NULL
28	NULL
)	NULL
were	NULL
gifts	NULL
from	NULL
Dr.	NULL
Erik	NULL
K.	NULL
Flemington	NULL
(	NULL
Dana-Farber	NULL
Cancer	NULL
Institute	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

NFAT1	NULL
Expression	NULL
Plasmids	NULL
.	NULL

-	NULL
The	NULL
pEFTAG	NULL
,	NULL
pLGP-mNFAT1-C	NULL
,	NULL
and	NULL
pEFTAG-mNFAT1-C	NULL
expression	NULL
plasmids	NULL
have	NULL
been	NULL
described	NULL
(	NULL
8	NULL
)	NULL
.	NULL

The	NULL
pEFTAG-NFAT1	NULL
(	NULL
1-415	NULL
)	NULL
plasmid	NULL
was	NULL
made	NULL
by	NULL
subcloning	NULL
the	NULL
Xmal-Xbal	NULL
fragment	NULL
of	NULL
GAL4-NFAT1	NULL
(	NULL
1-415	NULL
)	NULL
into	NULL
pEFTAG	NULL
between	NULL
the	NULL
Not1	NULL
and	NULL
Xbal	NULL
sites	NULL
.	NULL

The	NULL
pEFTAG-NFATIAN	NULL
plasmid	NULL
,	NULL
which	NULL
encodes	NULL
amino	NULL
acids	NULL
399-927	NULL
of	NULL
murine	NULL
NFAT1-C	NULL
,	NULL
was	NULL
constructed	NULL
by	NULL
subcloning	NULL
the	NULL
Xhol-Xbal	NULL
fragment	NULL
of	NULL
pEFTAG-mNFAT1-C	NULL
into	NULL
pEFTAG	NULL
between	NULL
the	NULL
Not1	NULL
and	NULL
Xbal	NULL
sites	NULL
.	NULL

The	NULL
pEFTAG-NFAT1DBD	NULL
and	NULL
pEFTAG-NFAT1DBDn	NULL
expression	NULL
plasmids	NULL
,	NULL
which	NULL
encode	NULL
amino	NULL
acids	NULL
398-694	NULL
and	NULL
398-584	NULL
of	NULL
murine	NULL
NFAT	NULL
1	NULL
,	NULL
respectively	NULL
,	NULL
were	NULL
constructed	NULL
by	NULL
subcloning	NULL
the	NULL
KpnI-Blpl	NULL
fragment	NULL
of	NULL
NFATpXS	NULL
(	NULL
1-297	NULL
)	NULL
and	NULL
NFATpXS	NULL
(	NULL
1-187	NULL
)	NULL
(	NULL
22	NULL
)	NULL
into	NULL
the	NULL
NotI	NULL
site	NULL
of	NULL
pEFTAG	NULL
.	NULL

Reporter	NULL
Plasmids	NULL
.	NULL

The	NULL
pBLCAT5S/NFAT3X	NULL
reporter	NULL
plas-	NULL
mid	NULL
has	NULL
been	NULL
described	NULL
(	NULL
8	NULL
)	NULL
.	NULL

The	NULL
pBLCAT5/NFAT	NULL
(	NULL
M3	NULL
}	NULL
3X	NULL
and	NULL
pBLCAT5/NFAT	NULL
(	NULL
M4	NULL
)	NULL
3X	NULL
reporter	NULL
plasmids	NULL
were	NULL
made	NULL
by	NULL
replacing	NULL
the	NULL
trimer	NULL
of	NULL
NFAT	NULL
sites	NULL
in	NULL
pBLCAT5/NFAT3X	NULL
with	NULL
trimers	NULL
of	NULL
NFAT	NULL
(	NULL
M3	NULL
)	NULL
and	NULL
NFAT	NULL
(	NULL
M4	NULL
)	NULL
(	NULL
22	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
NFAT3X-Luc	NULL
and	NULL
5'IL2-Luc	NULL
plasmids	NULL
were	NULL
kind	NULL
gifts	NULL
from	NULL
Dr.	NULL
David	NULL
McKean	NULL
(	NULL
Mayo	NULL
Clinic	NULL
,	NULL
Rochester	NULL
,	NULL
MN	NULL
)	NULL
.	NULL

Results	NULL
and	NULL
Discussion	NULL
We	NULL
assessed	NULL
the	NULL
intrinsic	NULL
transactivation	NULL
potential	NULL
of	NULL
the	NULL
NH	NULL
,	NULL
-	NULL
and	NULL
COOH-terminal	NULL
regions	NULL
of	NULL
NFAT1	NULL
,	NULL
that	NULL
flank	NULL
the	NULL
centrally	NULL
located	NULL
DBD	NULL
,	NULL
by	NULL
testing	NULL
chimeric	NULL
proteins	NULL
in	NULL
which	NULL
amino	NULL
acids	NULL
1-415	NULL
and	NULL
727-927	NULL
of	NULL
NFAT1	NULL
were	NULL
fused	NULL
to	NULL
the	NULL
COOH	NULL
terminus	NULL
of	NULL
the	NULL
heterologous	NULL
DBD	NULL
of	NULL
GAL4	NULL
.	NULL

Both	NULL
regions	NULL
have	NULL
features	NULL
resembling	NULL
TADs	NULL
:	NULL
the	NULL
NH-terminal	NULL
region	NULL
is	NULL
acidic	NULL
and	NULL
proline	NULL
rich	NULL
,	NULL
whereas	NULL
the	NULL
COOH-terminal	NULL
region	NULL
is	NULL
glutamine	NULL
and	NULL
proline	NULL
rich	NULL
(	NULL
8	NULL
)	NULL
.	NULL

When	NULL
expressed	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
,	NULL
both	NULL
chimeric	NULL
proteins	NULL
were	NULL
capable	NULL
of	NULL
transactivation	NULL
,	NULL
provided	NULL
that	NULL
the	NULL
reporter	NULL
plasmid	NULL
contained	NULL
GAL4	NULL
binding	NULL
sites	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
A	NULL
,	NULL
compare	NULL
lane	NULL
2	NULL
with	NULL
lane	NULL
3	NULL
and	NULL
lane	NULL
4	NULL
with	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

The	NULL
GAL4	NULL
DBD	NULL
alone	NULL
was	NULL
inactive	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

The	NULL
difference	NULL
in	NULL
the	NULL
activities	NULL
of	NULL
GAL4-NFAT1	NULL
(	NULL
1-415	NULL
)	NULL
and	NULL
GAL4-NFAT1	NULL
(	NULL
727-927	NULL
)	NULL
may	NULL
be	NULL
a	NULL
consequence	NULL
of	NULL
differences	NULL
in	NULL
the	NULL
level	NULL
of	NULL
expression	NULL
of	NULL
the	NULL
two	NULL
GAL4	NULL
fusion	NULL
proteins	NULL
,	NULL
or	NULL
may	NULL
reflect	NULL
an	NULL
intrinsic	NULL
difference	NULL
in	NULL
their	NULL
ability	NULL
to	NULL
transactivate	NULL
in	NULL
this	NULL
context	NULL
.	NULL

When	NULL
cells	NULL
expressing	NULL
the	NULL
GAL4-NFAT1	NULL
(	NULL
1-415	NULL
)	NULL
chimeric	NULL
protein	NULL
were	NULL
stimulated	NULL
with	NULL
the	NULL
calcium	NULL
ionophore	NULL
,	NULL
ionomycin	NULL
,	NULL
GAL4-dependent	NULL
transactivation	NULL
was	NULL
reproducibly	NULL
enhanced	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
B	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
;	NULL
2.0	NULL
+	NULL
0.4-fold	NULL
,	NULL
n	NULL
=	NULL
8	NULL
)	NULL
.	NULL

Stimulation	NULL
with	NULL
PMA	NULL
alone	NULL
had	NULL
no	NULL
effect	NULL
(	NULL
lane	NULL
3	NULL
;	NULL
0.8	NULL
+	NULL
0.1-fold	NULL
,	NULL
x	NULL
=	NULL
3	NULL
)	NULL
,	NULL
and	NULL
stimulation	NULL
with	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
did	NULL
not	NULL
increase	NULL
the	NULL
level	NULL
of	NULL
CAT	NULL
activity	NULL
over	NULL
that	NULL
observed	NULL
with	NULL
ionomycin	NULL
alone	NULL
(	NULL
lane	NULL
4	NULL
;	NULL
2.5	NULL
+	NULL
0.9-fold	NULL
,	NULL
n	NULL
=	NULL
3	NULL
)	NULL
.	NULL

Notably	NULL
,	NULL
CsA	NULL
completely	NULL
blocked	NULL
the	NULL
ionomycin-induced	NULL
increase	NULL
in	NULL
CAT	NULL
activity	NULL
mediated	NULL
by	NULL
the	NULL
GAL4-NFAT1	NULL
(	NULL
1-415	NULL
)	NULL
chimeric	NULL
protein	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
B	NULL
;	NULL
lanes	NULL
5-8	NULL
)	NULL
.	NULL

CsA	NULL
did	NULL
not	NULL
block	NULL
the	NULL
basal	NULL
level	NULL
of	NULL
transactivation	NULL
mediated	NULL
by	NULL
this	NULL
protein	NULL
in	NULL
unstimulated	NULL
Jurkat	NULL
cells	NULL
,	NULL
indicating	NULL
that	NULL
CsA	NULL
does	NULL
not	NULL
suppress	NULL
the	NULL
transcriptional	NULL
function	NULL
of	NULL
the	NULL
chimera	NULL
per	NULL
se	NULL
.	NULL

Transactivation	NULL
by	NULL
the	NULL
GAL4-NFAT1	NULL
(	NULL
727-927	NULL
)	NULL
chimeric	NULL
protein	NULL
was	NULL
not	NULL
affected	NULL
by	NULL
ionomycin	NULL
,	NULL
PMA	NULL
,	NULL
or	NULL
CsA	NULL
{	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
although	NULL
both	NULL
the	NULL
NH	NULL
;	NULL
-	NULL
and	NULL
COOH-terminal	NULL
regions	NULL
of	NULL
NFAT1	NULL
possessed	NULL
transactivating	NULL
function	NULL
,	NULL
only	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
NH	NULL
,	NULL
-terminal	NULL
region	NULL
of	NULL
NFAT1	NULL
was	NULL
capable	NULL
of	NULL
being	NULL
regulated	NULL
in	NULL
a	NULL
calcium-	NULL
and	NULL
calcineurin-dependent	NULL
fashion	NULL
.	NULL

The	NULL
lack	NULL
of	NULL
effect	NULL
of	NULL
PMA	NULL
on	NULL
the	NULL
transactivation	NULL
activities	NULL
of	NULL
these	NULL
chimeras	NULL
suggests	NULL
that	NULL
the	NULL
intrinsic	NULL
transactivation	NULL
activity	NULL
of	NULL
NFAT	NULL
!	NULL

1	NULL
is	NULL
not	NULL
regulated	NULL
by	NULL
PMA-stimulated	NULL
signaling	NULL
pathways	NULL
.	NULL

The	NULL
(	NULL
1-415	NULL
)	NULL
region	NULL
of	NULL
NFAT1	NULL
contains	NULL
a	NULL
unique	NULL
region	NULL
(	NULL
amino	NULL
acids	NULL
1-~100	NULL
)	NULL
not	NULL
represented	NULL
in	NULL
the	NULL
other	NULL
NFAT	NULL
family	NULL
proteins	NULL
,	NULL
as	NULL
well	NULL
as	NULL
an	NULL
adjacent	NULL
~300-amino	NULL
acid	NULL
NHR	NULL
(	NULL
amino	NULL
acids	NULL
~100-~380	NULL
)	NULL
that	NULL
shows	NULL
a	NULL
moderate	NULL
level	NULL
of	NULL
sequence	NULL
conservation	NULL
within	NULL
the	NULL
NFAT	NULL
family	NULL
142	NULL
Mechanisms	NULL
of	NULL
Transactivation	NULL
by	NULL
Nuclear	NULL
Factor	NULL
of	NULL
Activated	NULL
T	NULL
Cells	NULL
A	NULL
_	NULL
m	NULL
far	NULL
fart	NULL
e	NULL
-	NULL
@	NULL
$	NULL
$	NULL
v-	NULL
h	NULL
ant	NULL
om	NULL
-	NULL
Tm	NULL
-	NULL
T	NULL
ar	NULL
-	NULL
§	NULL
B	NULL
8s	NULL
to	NULL
o	NULL
5	NULL
}	NULL
y-	NULL
r-	NULL
r-	NULL
r-	NULL
<	NULL
c	NULL
<	NULL
R	NULL
f	NULL
_	NULL
é	NULL
;	NULL
E	NULL
;	NULL
58	NULL
E	NULL
;	NULL
58	NULL
Stimulation	NULL
-	NULL
_	NULL
|	NULL
-_	NULL
P_	NULL
P+	NULL
|	NULL
-P	NULL
P+	NULL
GG	NULL
zOo	NULL
zm	NULL
z0	NULL
zm	NULL
CsA	NULL
o	NULL
n	NULL
eom	NULL
e	NULL
f	NULL
eom	NULL
:	NULL
orer	NULL
me	NULL
°	NULL
h	NULL
f	NULL
f	NULL
iX	NULL
ARe	NULL
797.35	NULL
“	NULL
:	NULL
‘	NULL
I	NULL
5	NULL
6	NULL
8	NULL
Fold	NULL
Induction	NULL
1.0	NULL
25	NULL
0.69	NULL
2.1	NULL
0.94	NULL
0.95	NULL
0.88	NULL
0.76	NULL
C	NULL
|	NULL
_D/EP	NULL
|	NULL
«	NULL
relative	NULL
fold	NULL
mawman	NULL
-	NULL
tono	NULL
CAT	NULL
activity	NULL
_	NULL
induction	NULL
-	NULL
(	NULL
®	NULL
°	NULL
0.05	NULL
+	NULL
0.07	NULL
1	NULL
GAL4DBD	NULL
“	NULL
ti	NULL
“	NULL
$	NULL
1	NULL
*	NULL
+	NULL
(	NULL
@	NULL
-	NULL
-	NULL
0.02	NULL
+	NULL
0.03	NULL
.	NULL

k	NULL
sn	NULL
1	NULL
415	NULL
-	NULL
ﬂ	NULL
/	NULL
1.0	NULL
2	NULL
am	NULL
17415	NULL
4	NULL
a	NULL
_	NULL
3	NULL
2.12	NULL
+	NULL
0.40	NULL
S7	NULL
-	NULL
[	NULL
@	NULL
f	NULL
te	NULL
3	NULL
-	NULL
17415	NULL
..	NULL
@	NULL
_|	NULL
0.0620.05	NULL
145	NULL
-	NULL
``	NULL
0.08	NULL
+	NULL
0.04	NULL
4	NULL
eton	NULL
cat	NULL
415	NULL
|	NULL
.	NULL

[	NULL
®	NULL
___	NULL
0.10+0.06	NULL
259	NULL
259-415	NULL
~	NULL
A	NULL
___	NULL
_	NULL
0.16+0.08	NULL
5	NULL
+	NULL
Wo	NULL
=	NULL
|019+0.12	NULL
a	NULL
203	NULL
1.293	NULL
-	NULL
®	NULL
__	NULL
9062009	NULL
+	NULL
©	NULL
0192012	NULL
452	NULL
s	NULL
-	NULL
@	NULL
_	NULL
_	NULL
0372010	NULL
'-	NULL
opaca	NULL
.	NULL

ASP1	NULL
t	NULL
*	NULL
>	NULL
&	NULL
``	NULL
.68	NULL
+	NULL
0.	NULL
c	NULL
%	NULL
+	NULL
®	NULL
0	NULL
-	NULL
0.9220.06	NULL
2.68	NULL
+	NULL
0.81	NULL
1	NULL
;	NULL
:	NULL
.	NULL

&	NULL
>	NULL
230	NULL
-	NULL
®	NULL
-	NULL
©	NULL
029+0.09	NULL
:	NULL
o	NULL
1220	NULL
4	NULL
@	NULL
_	NULL
171	NULL
-	NULL
(	NULL
06K	NULL
~A	NULL
%	NULL
K	NULL
:	NULL
*~	NULL
im	NULL
;	NULL
MoE	NULL
ois	NULL
+	NULL
B	NULL
-a	NULL
&	NULL
19.3	NULL
+8.74	NULL
10	NULL
144	NULL
388	NULL
-	NULL
_-	NULL
671233	NULL
s	NULL
lie	NULL
le	NULL
mJ	NULL
___	NULL
SP2	NULL
q	NULL
.	NULL

00	NULL
a	NULL
W	NULL
se	NULL
.	NULL

11	NULL
144	NULL
259	NULL
sg	NULL
~	NULL
WB	NULL
-	NULL
R/	NULL
6.57	NULL
+180	NULL
Misael	NULL
8	NULL
``	NULL
a	NULL
e	NULL
-	NULL
a	NULL
s57£101	NULL
._	NULL
Figure	NULL
1	NULL
.	NULL

-	NULL
The	NULL
transactivation	NULL
and	NULL
regulatory	NULL
domains	NULL
of	NULL
NFAT1	NULL
.	NULL

(	NULL
A4	NULL
)	NULL
NFAT1	NULL
has	NULL
two	NULL
independent	NULL
transactivation	NULL
domains	NULL
.	NULL

Jurkat	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
5	NULL
pug	NULL
of	NULL
RSV-GAL4DBD	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
,	NULL
GAL4-NFAT1	NULL
(	NULL
1-415	NULL
)	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
,	NULL
or	NULL
GAL4-NFAT1	NULL
(	NULL
727-927	NULL
)	NULL
(	NULL
lanes	NULL
4	NULL
and	NULL
5	NULL
)	NULL
together	NULL
with	NULL
5	NULL
jug	NULL
of	NULL
reporter	NULL
plasmid	NULL
of	NULL
GAL4-CAT	NULL
(	NULL
lanes	NULL
1	NULL
,	NULL
2	NULL
,	NULL
and	NULL
4	NULL
)	NULL
or	NULL
BG-CAT	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
5	NULL
)	NULL
and	NULL
assayed	NULL
for	NULL
CAT	NULL
activity	NULL
2	NULL
d	NULL
later	NULL
,	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

(	NULL
B	NULL
)	NULL
The	NULL
transactivation	NULL
activity	NULL
of	NULL
the	NULL
GAL4-hNFAT1	NULL
(	NULL
1-415	NULL
)	NULL
chimera	NULL
protein	NULL
is	NULL
induced	NULL
by	NULL
ionomycin	NULL
stimulation	NULL
and	NULL
is	NULL
sensitive	NULL
to	NULL
CsA	NULL
.	NULL

Jurkat	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
5	NULL
pug	NULL
of	NULL
GAL4-hNFAT1	NULL
(	NULL
1-415	NULL
)	NULL
and	NULL
5	NULL
g	NULL
of	NULL
GAL4-CAT	NULL
plasmids	NULL
and	NULL
cultured	NULL
in	NULL
eight	NULL
aliquots	NULL
.	NULL

Cells	NULL
were	NULL
left	NULL
unstimulated	NULL
{	NULL
lanes	NULL
1	NULL
and	NULL
5	NULL
)	NULL
,	NULL
or	NULL
stimulated	NULL
overnight	NULL
with	NULL
1	NULL
pM	NULL
ionomycin	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
6	NULL
)	NULL
,	NULL
10	NULL
nM	NULL
PMA	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
7	NULL
)	NULL
,	NULL
or	NULL
both	NULL
(	NULL
lanes	NULL
4	NULL
and	NULL
8	NULL
)	NULL
,	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
lanes	NULL
1-4	NULL
)	NULL
or	NULL
presence	NULL
(	NULL
lanes	NULL
5-8	NULL
)	NULL
of	NULL
1	NULL
M	NULL
CsA	NULL
.	NULL

Shown	NULL
is	NULL
a	NULL
CAT	NULL
assay	NULL
representative	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Relative	NULL
transactivation	NULL
activity	NULL
of	NULL
GAL4	NULL
fusion	NULL
proteins	NULL
with	NULL
various	NULL
NFAT1	NULL
NH	NULL
;	NULL
-terminal	NULL
fragments	NULL
.	NULL

The	NULL
GAL4	NULL
fusion	NULL
proteins	NULL
were	NULL
expressed	NULL
in	NULL
Jurkat	NULL
cells	NULL
without	NULL
(	NULL
-	NULL
)	NULL
or	NULL
with	NULL
(	NULL
+	NULL
)	NULL
ionomycin	NULL
(	NULL
fono	NULL
)	NULL
stimulation	NULL
.	NULL

Transfection	NULL
efficiencies	NULL
were	NULL
normalized	NULL
by	NULL
measuring	NULL
hGH	NULL
expression	NULL
from	NULL
a	NULL
cotransfected	NULL
RSV-hGH	NULL
plasmid	NULL
.	NULL

Relative	NULL
CAT	NULL
activities	NULL
(	NULL
mean	NULL
+	NULL
SD	NULL
,	NULL
n	NULL
=	NULL
3	NULL
)	NULL
shown	NULL
are	NULL
CAT	NULL
activities	NULL
normalized	NULL
to	NULL
that	NULL
of	NULL
unstimulated	NULL
cells	NULL
transfected	NULL
with	NULL
GAL4-hLNFAT1	NULL
(	NULL
1-415	NULL
)	NULL
.	NULL

Fold	NULL
induction	NULL
is	NULL
shown	NULL
where	NULL
there	NULL
is	NULL
significant	NULL
difference	NULL
between	NULL
CAT	NULL
activities	NULL
of	NULL
unstimulated	NULL
and	NULL
ionomycin	NULL
stimulated	NULL
cells	NULL
(	NULL
P	NULL
<	NULL
0.02	NULL
)	NULL
.	NULL

(	NULL
8	NULL
)	NULL
.	NULL

Detailed	NULL
inspection	NULL
of	NULL
the	NULL
NHR	NULL
reveals	NULL
the	NULL
presence	NULL
of	NULL
several	NULL
strongly	NULL
conserved	NULL
sequence	NULL
motifs	NULL
(	NULL
8	NULL
)	NULL
,	NULL
including	NULL
three	NULL
repeats	NULL
of	NULL
the	NULL
SP	NULL
motifs	NULL
(	NULL
6	NULL
)	NULL
(	NULL
consensus	NULL
sequence	NULL
,	NULL
SPxxSPxxSPxxxxx	NULL
[	NULL
D/EJ	NULL
[	NULL
D/E	NULL
]	NULL
)	NULL
.	NULL

To	NULL
localize	NULL
the	NULL
regions	NULL
within	NULL
the	NULL
GAL4-NFATIi	NULL
(	NULL
1-415	NULL
)	NULL
protein	NULL
required	NULL
for	NULL
transactivation	NULL
and	NULL
regulation	NULL
by	NULL
ionomycin	NULL
,	NULL
we	NULL
tested	NULL
GAL4	NULL
chimeric	NULL
proteins	NULL
containing	NULL
NH	NULL
,	NULL
-	NULL
or	NULL
COOH	NULL
-terminally	NULL
deleted	NULL
derivatives	NULL
of	NULL
the	NULL
NFAT1	NULL
(	NULL
1-415	NULL
)	NULL
fragment	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
C	NULL
)	NULL
.	NULL

These	NULL
proteins	NULL
were	NULL
expressed	NULL
in	NULL
Jurkat	NULL
cells	NULL
with	NULL
the	NULL
GAL4-CAT	NULL
reporter	NULL
plasmid	NULL
.	NULL

Deletion	NULL
of	NULL
as	NULL
few	NULL
as	NULL
57	NULL
residues	NULL
from	NULL
the	NULL
NH	NULL
,	NULL
;	NULL
terminus	NULL
of	NULL
NFAT1	NULL
abolished	NULL
transactivation	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
C	NULL
,	NULL
row	NULL
3	NULL
)	NULL
,	NULL
and	NULL
further	NULL
deletions	NULL
did	NULL
not	NULL
restore	NULL
function	NULL
(	NULL
rows	NULL
4	NULL
and	NULL
5	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
chimeric	NULL
proteins	NULL
containing	NULL
deletions	NULL
of	NULL
up	NULL
to	NULL
185	NULL
residues	NULL
from	NULL
the	NULL
COOH	NULL
terminus	NULL
of	NULL
the	NULL
1-415	NULL
region	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
C	NULL
,	NULL
rows	NULL
6-10	NULL
)	NULL
retained	NULL
the	NULL
ability	NULL
to	NULL
mediate	NULL
transactivation	NULL
.	NULL

The	NULL
low	NULL
basal	NULL
activities	NULL
of	NULL
proteins	NULL
containing	NULL
the	NULL
NH	NULL
,	NULL
-terminal	NULL
half	NULL
of	NULL
the	NULL
NHR	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
C	NULL
,	NULL
rows	NULL
6-8	NULL
)	NULL
were	NULL
likely	NULL
due	NULL
to	NULL
their	NULL
low	NULL
level	NULL
of	NULL
expression	NULL
,	NULL
since	NULL
increasing	NULL
the	NULL
amount	NULL
of	NULL
plasmid	NULL
DNA	NULL
in	NULL
transfections	NULL
led	NULL
to	NULL
higher	NULL
basal	NULL
activities	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
;	NULL
however	NULL
their	NULL
transactivation	NULL
activities	NULL
were	NULL
clearly	NULL
augmented	NULL
in	NULL
ionomycin-stimulated	NULL
cells	NULL
(	NULL
row	NULL
6-8	NULL
)	NULL
.	NULL

Deletions	NULL
of	NULL
most	NULL
of	NULL
the	NULL
NHR	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
C	NULL
,	NULL
rows	NULL
9	NULL
and	NULL
10	NULL
)	NULL
,	NULL
or	NULL
the	NULL
NH	NULL
;	NULL
-terminal	NULL
half	NULL
of	NULL
the	NULL
NHR	NULL
(	NULL
row	NULL
11	NULL
)	NULL
,	NULL
resulted	NULL
in	NULL
high	NULL
basal	NULL
activities	NULL
that	NULL
were	NULL
not	NULL
further	NULL
increased	NULL
by	NULL
stimulation	NULL
with	NULL
ionomycin	NULL
,	NULL
even	NULL
when	NULL
the	NULL
amount	NULL
of	NULL
plasmid	NULL
DNA	NULL
used	NULL
in	NULL
the	NULL
transfection	NULL
was	NULL
titrated	NULL
to	NULL
yield	NULL
a	NULL
lower	NULL
basal	NULL
level	NULL
of	NULL
CAT	NULL
activity	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicated	NULL
that	NULL
the	NULL
NH	NULL
,	NULL
-terminal	NULL
region	NULL
of	NULL
NFAT1	NULL
contains	NULL
a	NULL
strong	NULL
TAD	NULL
encoded	NULL
within	NULL
amino	NULL
acids	NULL
1-144	NULL
.	NULL

However	NULL
,	NULL
the	NULL
activity	NULL
of	NULL
this	NULL
TAD	NULL
is	NULL
fully	NULL
revealed	NULL
only	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
amino	NULL
acids	NULL
145-387	NULL
,	NULL
which	NULL
constitute	NULL
essentially	NULL
all	NULL
of	NULL
the	NULL
NHR	NULL
.	NULL

In	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
NHR	NULL
,	NULL
moreover	NULL
,	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
NH-terminal	NULL
TAD	NULL
of	NULL
NFAT	NULL
1	NULL
was	NULL
regulated	NULL
in	NULL
a	NULL
calcium	NULL
/calcineurin-dependent	NULL
manner	NULL
.	NULL

Indeed	NULL
,	NULL
we	NULL
found	NULL
that	NULL
the	NULL
NHR	NULL
was	NULL
capable	NULL
of	NULL
conferring	NULL
a	NULL
small	NULL
degree	NULL
of	NULL
ionomycin	NULL
responsiveness	NULL
on	NULL
an	NULL
unrelated	NULL
protein	NULL
,	NULL
since	NULL
transactivation	NULL
by	NULL
a	NULL
chimeric	NULL
protein	NULL
(	NULL
GAL4-BB-E2F	NULL
)	NULL
,	NULL
in	NULL
which	NULL
amino	NULL
acids	NULL
57-318	NULL
of	NULL
NFAT1	NULL
were	NULL
introduced	NULL
between	NULL
the	NULL
GAL4	NULL
DBD	NULL
and	NULL
the	NULL
E2F	NULL
TAD	NULL
,	NULL
was	NULL
significantly	NULL
stimulated	NULL
by	NULL
ionomycin	NULL
treatment	NULL
of	NULL
Jurkat	NULL
cells	NULL
(	NULL
1.65	NULL
+	NULL
#	NULL
0.1-fold	NULL
induction	NULL
,	NULL
n	NULL
=	NULL
6	NULL
,	NULL
P	NULL
<	NULL
0.001	NULL
)	NULL
.	NULL

CsA	NULL
pretreatment	NULL
reproducibly	NULL
blocked	NULL
the	NULL
ionomycin-mediated	NULL
stimulation	NULL
(	NULL
1.02	NULL
+	NULL
0.32-fold	NULL
induction	NULL
,	NULL
n	NULL
=	NULL
6	NULL
)	NULL
,	NULL
but	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
basal	NULL
level	NULL
of	NULL
transactivation	NULL
.	NULL

The	NULL
level	NULL
of	NULL
transactivation	NULL
by	NULL
the	NULL
parent	NULL
GAL4-E2F	NULL
chimera	NULL
was	NULL
unaffected	NULL
by	NULL
ionomycin	NULL
stimulation	NULL
(	NULL
0.96	NULL
+	NULL
0.2-fold	NULL
induction	NULL
,	NULL
n	NULL
=	NULL
3	NULL
)	NULL
.	NULL

We	NULL
compared	NULL
the	NULL
transactivation	NULL
functions	NULL
of	NULL
full-length	NULL
NFAT	NULL
!	NULL

with	NULL
those	NULL
of	NULL
NFAT1	NULL
(	NULL
399-927	NULL
)	NULL
(	NULL
here	NULL
termed	NULL
NFAT1IAN	NULL
)	NULL
,	NULL
which	NULL
lacks	NULL
the	NULL
NH-terminal	NULL
TAD	NULL
and	NULL
NHR	NULL
.	NULL

Expression	NULL
of	NULL
either	NULL
protein	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
resulted	NULL
in	NULL
increased	NULL
basal	NULL
transactivation	NULL
of	NULL
a	NULL
CAT	NULL
reporter	NULL
plasmid	NULL
containing	NULL
three	NULL
copies	NULL
of	NULL
the	NULL
NFAT	NULL
site	NULL
of	NULL
the	NULL
murine	NULL
IL-2	NULL
promoter	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
further	NULL
induction	NULL
of	NULL
CAT	NULL
activity	NULL
by	NULL
full-length	NULL
recombinant	NULL
NFAT1	NULL
required	NULL
stimulation	NULL
with	NULL
both	NULL
ionomycin	NULL
and	NULL
PMA	NULL
,	NULL
and	NULL
was	NULL
completely	NULL
inhib-	NULL
ited	NULL
by	NULL
pretreatment	NULL
with	NULL
CsA	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
leff	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
transactivation	NULL
by	NULL
NFATIAN	NULL
was	NULL
stimulated	NULL
by	NULL
PMA	NULL
alone	NULL
and	NULL
was	NULL
not	NULL
inhibited	NULL
by	NULL
pretreatment	NULL
with	NULL
CsA	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
right	NULL
)	NULL
.	NULL

We	NULL
have	NULL
previously	NULL
shown	NULL
that	NULL
full-length	NULL
is	NULL
cytoplasmic	NULL
in	NULL
resting	NULL
T	NULL
cells	NULL
and	NULL
translocates	NULL
into	NULL
the	NULL
nucleus	NULL
upon	NULL
ionomycin	NULL
stimulation	NULL
(	NULL
8	NULL
)	NULL
,	NULL
whereas	NULL
NFAT1AN	NULL
is	NULL
diffusely	NULL
distributed	NULL
throughout	NULL
the	NULL
nucleus	NULL
and	NULL
the	NULL
cytoplasm	NULL
in	NULL
both	NULL
resting	NULL
and	NULL
stimulated	NULL
cells	NULL
(	NULL
29	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
results	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
indicate	NULL
that	NULL
nuclearly	NULL
localized	NULL
NFAT1	NULL
and	NULL
NFAT1AN	NULL
require	NULL
PMA	NULL
for	NULL
optimal	NULL
transactivation	NULL
,	NULL
whereas	NULL
ionomycin	NULL
is	NULL
required	NULL
only	NULL
for	NULL
transloca-tion	NULL
of	NULL
full-length	NULL
NFAT1	NULL
into	NULL
the	NULL
nucleus	NULL
.	NULL

Given	NULL
that	NULL
PMA	NULL
does	NULL
not	NULL
stimulate	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
intrinsic	NULL
TADs	NULL
of	NULL
NFAT1	NULL
(	NULL
see	NULL
above	NULL
)	NULL
,	NULL
we	NULL
postulated	NULL
that	NULL
the	NULL
PMA	NULL
requirement	NULL
for	NULL
transactivation	NULL
most	NULL
likely	NULL
reflected	NULL
the	NULL
requirement	NULL
for	NULL
cooperation	NULL
of	NULL
NFAT1	NULL
with	NULL
PMA-stimu-lated	NULL
transcription	NULL
factors	NULL
such	NULL
as	NULL
Fos	NULL
and	NULL
Jun	NULL
(	NULL
1	NULL
)	NULL
.	NULL

To	NULL
evaluate	NULL
the	NULL
contribution	NULL
of	NULL
cooperating	NULL
nuclear	NULL
proteins	NULL
to	NULL
NFAT	NULL
1-dependent	NULL
transcription	NULL
,	NULL
we	NULL
tested	NULL
whether	NULL
the	NULL
DBD	NULL
of	NULL
NFAT1	NULL
(	NULL
which	NULL
is	NULL
sufficient	NULL
for	NULL
cooperation	NULL
with	NULL
Fos	NULL
and	NULL
Jun	NULL
proteins	NULL
;	NULL
22	NULL
)	NULL
could	NULL
independently	NULL
mediate	NULL
transactivation	NULL
.	NULL

Expression	NULL
of	NULL
NFAT1DBD	NULL
(	NULL
amino	NULL
acids	NULL
398-694	NULL
of	NULL
murine	NULL
NFAT1	NULL
)	NULL
caused	NULL
transactivation	NULL
of	NULL
a	NULL
luciferase	NULL
reporter	NULL
plasmid	NULL
containing	NULL
three	NULL
tandem	NULL
NFAT	NULL
sites	NULL
(	NULL
NFAT3X-Luc	NULL
)	NULL
in	NULL
unstimulated	NULL
Jurkat	NULL
T	NULL
cells	NULL
,	NULL
and	NULL
stimulation	NULL
with	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
greatly	NULL
increased	NULL
the	NULL
level	NULL
of	NULL
transactivation	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
A	NULL
,	NULL
leff	NULL
)	NULL
.	NULL

This	NULL
effect	NULL
is	NULL
probably	NULL
not	NULL
due	NULL
to	NULL
an	NULL
intrinsic	NULL
transactivation	NULL
function	NULL
possessed	NULL
by	NULL
the	NULL
DBD	NULL
,	NULL
since	NULL
a	NULL
longer	NULL
fragment	NULL
of	NULL
NFAT	NULL
1	NULL
containing	NULL
the	NULL
NFAT1IDBD	NULL
does	NULL
not	NULL
show	NULL
transactivation	NULL
activity	NULL
in	NULL
vitro	NULL
(	NULL
4	NULL
)	NULL
.	NULL

The	NULL
effect	NULL
is	NULL
striking	NULL
because	NULL
isolated	NULL
DNA-binding	NULL
fragments	NULL
of	NULL
other	NULL
transcription	NULL
factors	NULL
usually	NULL
inhibit	NULL
transactivation	NULL
when	NULL
overexpressed	NULL
,	NULL
most	NULL
likely	NULL
by	NULL
competing	NULL
for	NULL
endogenous	NULL
dimerization	NULL
partners	NULL
and/or	NULL
blocking	NULL
the	NULL
relevant	NULL
sites	NULL
on	NULL
DNA	NULL
(	NULL
30	NULL
,	NULL
31	NULL
)	NULL
.	NULL

NFATIAN	NULL
&	NULL
9	NULL
0	NULL
3	NULL
TC	NULL
£	NULL
k=	NULL
O	NULL
LL	NULL
CSA	NULL
-	NULL
+	NULL
-	NULL
+	NULL
Figure	NULL
2	NULL
.	NULL

-	NULL
Transactivation	NULL
by	NULL
full-length	NULL
NFAT1	NULL
and	NULL
a	NULL
fragment	NULL
lack	NULL
ing	NULL
the	NULL
NH-terminal	NULL
domain	NULL
.	NULL

Jurkat	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
5	NULL
pg	NULL
of	NULL
the	NULL
NFAT1	NULL
(	NULL
lef	NULL
?	NULL
)	NULL

or	NULL
NFAT1IAN	NULL
(	NULL
right	NULL
)	NULL
expression	NULL
plasmids	NULL
and	NULL
1	NULL
jug	NULL
of	NULL
the	NULL
pBLCAT5/NFAT3X	NULL
reporter	NULL
plasmid	NULL
,	NULL
and	NULL
treated	NULL
1	NULL
d	NULL
later	NULL
with	NULL
solvent	NULL
(	NULL
blank	NULL
bars	NULL
)	NULL
,	NULL
ionomycin	NULL
(	NULL
striped	NULL
bars	NULL
)	NULL
,	NULL
PMA	NULL
(	NULL
stippled	NULL
bars	NULL
)	NULL
,	NULL
or	NULL
ionomycin	NULL
plus	NULL
PMA	NULL
(	NULL
solid	NULL
bars	NULL
)	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
--	NULL
)	NULL
or	NULL
presence	NULL
(	NULL
+	NULL
)	NULL
of	NULL
CsA	NULL
.	NULL

CAT	NULL
activity	NULL
was	NULL
assayed	NULL
2	NULL
d	NULL
after	NULL
transfection	NULL
.	NULL

The	NULL
fold	NULL
induction	NULL
(	NULL
mean	NULL
*	NULL
SD	NULL
,	NULL
n	NULL
=	NULL
3	NULL
)	NULL
of	NULL
CAT	NULL
activity	NULL
relative	NULL
to	NULL
unstimulated	NULL
cells	NULL
is	NULL
normalized	NULL
for	NULL
hGH	NULL
expression	NULL
.	NULL

144	NULL
Mechanisms	NULL
of	NULL
Transactivation	NULL
by	NULL
Nuclear	NULL
Factor	NULL
of	NULL
Activated	NULL
T	NULL
Cells	NULL
1200	NULL
,	NULL
NFAT	NULL
8000	NULL
1	NULL
j_.2	NULL
|	NULL
C	NULL
Unstim	NULL
6000	NULL
C	NULL
Unstim	NULL
2	NULL
1000	NULL
]	NULL
m	NULL
P+	NULL
!	NULL

2	NULL
4000	NULL
m	NULL
P+l	NULL
2	NULL
800	NULL
4	NULL
g	NULL
1200	NULL
4	NULL
0	NULL
o	NULL
@	NULL
6004	NULL
J	NULL
E	NULL
£3	NULL
800	NULL
;	NULL
o	NULL
400	NULL
;	NULL
'	NULL
o	NULL
3	NULL
3	NULL
-	NULL
!	NULL

-	NULL
'	NULL
4004	NULL
200	NULL
0	NULL
ir	NULL
l	NULL
1	NULL
1	NULL
I	NULL
0	NULL
4	NULL
I	NULL
,	NULL
‘	NULL
endog	NULL
FL	NULL
DBD	NULL
DBDn	NULL
endog	NULL
FL	NULL
DBD	NULL
DBDn	NULL
B	NULL
§	NULL
WT	NULL
,	NULL
Unstim	NULL
100	NULL
4	NULL
m	NULL
WT.P+	NULL
!	NULL

80	NULL
4	NULL
CJ	NULL
M3	NULL
,	NULL
Unstim	NULL
M3	NULL
,	NULL
P	NULL
+	NULL
|	NULL
é	NULL
``	NULL
60	NULL
{	NULL
C	NULL
)	NULL
M4	NULL
,	NULL
Unstim	NULL
g	NULL
40	NULL
-	NULL
B	NULL
M4	NULL
,	NULL
P+	NULL
]	NULL
O	NULL
C	NULL
'	NULL
_	NULL
<	NULL
O	NULL
i	NULL
TE	NULL
endog	NULL
FL	NULL
DBD	NULL
-	NULL
DBDr	NULL
Figure	NULL
3	NULL
.	NULL

The	NULL
DBD	NULL
of	NULL
NFAT1	NULL
causes	NULL
transcription	NULL
from	NULL
NFAT	NULL
sites	NULL
and	NULL
the	NULL
IL-2	NULL
promoter	NULL
.	NULL

(	NULL
4	NULL
)	NULL
Jurkat	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
10	NULL
jug	NULL
of	NULL
pEFTAG	NULL
(	NULL
endog	NULL
)	NULL
,	NULL
pEFTAGNFATI-C	NULL
(	NULL
FL	NULL
)	NULL
,	NULL
pEFTAGNFAT1IDBD	NULL
(	NULL
DBD	NULL
)	NULL
,	NULL
or	NULL
pEFTAGNFAT1IDBDn	NULL
(	NULL
DBDn	NULL
)	NULL
together	NULL
with	NULL
1	NULL
jpg	NULL
of	NULL
NFAT-Luc	NULL
(	NULL
NFAT	NULL
,	NULL
left	NULL
)	NULL
or	NULL
2	NULL
pug	NULL
of	NULL
5IL2-Luc	NULL
(	NULL
IL-2	NULL
,	NULL
right	NULL
)	NULL
reporter	NULL
plasmids	NULL
.	NULL

Luciferase	NULL
activity	NULL
(	NULL
in	NULL
light	NULL
units	NULL
)	NULL
was	NULL
assayed	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Jurkat	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
5	NULL
jug	NULL
of	NULL
the	NULL
indicated	NULL
expression	NULL
plasmids	NULL
and	NULL
1	NULL
pg	NULL
of	NULL
pBLCAT5/NFAT3X	NULL
(	NULL
WT	NULL
)	NULL
,	NULL
pBLCAT5/NFAT	NULL
(	NULL
M3	NULL
)	NULL
3X	NULL
(	NULL
M3	NULL
)	NULL
,	NULL
or	NULL
pBLCAT5/NFAT	NULL
(	NULL
M4	NULL
)	NULL
3X	NULL
(	NULL
M4	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
left	NULL
unstimulated	NULL
(	NULL
Unstim	NULL
)	NULL
or	NULL
were	NULL
stimulated	NULL
with	NULL
PMA	NULL
and	NULL
ionomycin	NULL
(	NULL
P	NULL
+	NULL
1	NULL
)	NULL
1	NULL
d	NULL
after	NULL
transfection	NULL
.	NULL

CAT	NULL
activity	NULL
was	NULL
assayed	NULL
2	NULL
d	NULL
after	NULL
transfection	NULL
.	NULL

The	NULL
data	NULL
shown	NULL
are	NULL
representative	NULL
of	NULL
at	NULL
least	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

NFAT1IDBD	NULL
contains	NULL
the	NULL
region	NULL
corresponding	NULL
to	NULL
both	NULL
the	NULL
NH	NULL
,	NULL
-terminal	NULL
specificity	NULL
subdomain	NULL
and	NULL
the	NULL
COOH-terminal	NULL
dimerization	NULL
domain	NULL
of	NULL
p50	NULL
NF-KB	NULL
(	NULL
32	NULL
,	NULL
33	NULL
)	NULL
.	NULL

However	NULL
the	NULL
smallest	NULL
fragment	NULL
of	NULL
NFAT1	NULL
capable	NULL
of	NULL
DNA	NULL
binding	NULL
and	NULL
cooperative	NULL
interaction	NULL
with	NULL
Fos	NULL
and	NULL
Jun	NULL
is	NULL
a	NULL
shorter	NULL
187-amino	NULL
acid	NULL
fragment	NULL
(	NULL
NFAT1DBDn	NULL
,	NULL
amino	NULL
acids	NULL
398-584	NULL
of	NULL
murine	NULL
NFAT1	NULL
)	NULL
that	NULL
corresponds	NULL
to	NULL
the	NULL
NH-terminal	NULL
specificity	NULL
subdomain	NULL
of	NULL
p50	NULL
NF-KB	NULL
(	NULL
32	NULL
,	NULL
33	NULL
)	NULL
.	NULL

Strik-ingly	NULL
,	NULL
NFAT1DBDn	NULL
was	NULL
also	NULL
able	NULL
to	NULL
mediate	NULL
the	NULL
inducible	NULL
transcription	NULL
of	NULL
NFAT3X-Luc	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
4	NULL
,	NULL
leff	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
both	NULL
NFAT1IDBD	NULL
and	NULL
NFAT1DBDn	NULL
increased	NULL
the	NULL
transcription	NULL
of	NULL
a	NULL
luciferase	NULL
reporter	NULL
gene	NULL
controlled	NULL
by	NULL
the	NULL
IL-2	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
A	NULL
,	NULL
right	NULL
)	NULL
.	NULL

In	NULL
this	NULL
case	NULL
,	NULL
the	NULL
increased	NULL
transcription	NULL
was	NULL
apparent	NULL
in	NULL
stimulated	NULL
but	NULL
not	NULL
in	NULL
unstimulated	NULL
Jurkat	NULL
T	NULL
cells	NULL
,	NULL
presumably	NULL
because	NULL
other	NULL
inducible	NULL
transcription	NULL
factors	NULL
such	NULL
as	NULL
NF-KB	NULL
are	NULL
required	NULL
for	NULL
IL-2	NULL
promoter	NULL
induction	NULL
(	NULL
3	NULL
)	NULL
.	NULL

The	NULL
binding	NULL
of	NULL
NFAT1DBD	NULL
and	NULL
NFAT1DBDn	NULL
to	NULL
the	NULL
145	NULL
Luo	NULL
et	NULL
al	NULL
.	NULL

composite	NULL
NFAT	NULL
site	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
is	NULL
greatly	NULL
stabilized	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
Fos	NULL
and	NULL
Jun	NULL
(	NULL
20	NULL
)	NULL
.	NULL

To	NULL
test	NULL
whether	NULL
the	NULL
transcriptional	NULL
activation	NULL
observed	NULL
to	NULL
be	NULL
mediated	NULL
by	NULL
these	NULL
fragments	NULL
was	NULL
due	NULL
to	NULL
AP-1	NULL
proteins	NULL
recruited	NULL
to	NULL
the	NULL
composite	NULL
site	NULL
,	NULL
we	NULL
used	NULL
CAT	NULL
reporter	NULL
plasmids	NULL
containing	NULL
mutated	NULL
NFAT	NULL
sites	NULL
.	NULL

The	NULL
M3	NULL
mutation	NULL
of	NULL
the	NULL
NFAT	NULL
site	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
abrogates	NULL
the	NULL
binding	NULL
of	NULL
NFAT	NULL
proteins	NULL
and	NULL
their	NULL
recruitment	NULL
of	NULL
AP-1	NULL
proteins	NULL
,	NULL
whereas	NULL
the	NULL
M4	NULL
mutation	NULL
permits	NULL
the	NULL
binding	NULL
of	NULL
NFAT	NULL
proteins	NULL
but	NULL
prevents	NULL
the	NULL
formation	NULL
of	NULL
the	NULL
NFAT-Fos-Jun	NULL
complex	NULL
(	NULL
22	NULL
,	NULL
34	NULL
)	NULL
.	NULL

Both	NULL
the	NULL
M3	NULL
and	NULL
M4	NULL
mutations	NULL
severely	NULL
compromised	NULL
transactivation	NULL
by	NULL
NFAT1DBD	NULL
and	NULL
NFAT1IDBDn	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
B	NULL
)	NULL
.	NULL

Western	NULL
analysis	NULL
of	NULL
the	NULL
epitope-tagged	NULL
NFAT1IDBD	NULL
confirmed	NULL
that	NULL
it	NULL
was	NULL
expressed	NULL
equivalently	NULL
in	NULL
each	NULL
transfection	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicated	NULL
that	NULL
transactivation	NULL
by	NULL
NFAT1IDBD	NULL
and	NULL
NFAT1DBDn	NULL
required	NULL
DNA	NULL
binding	NULL
by	NULL
the	NULL
NFAT1	NULL
fragments	NULL
and	NULL
recruitment	NULL
of	NULL
AP-1	NULL
proteins	NULL
or	NULL
other	NULL
cooperating	NULL
transcription	NULL
factors	NULL
to	NULL
the	NULL
adjacent	NULL
AP-1	NULL
site	NULL
,	NULL
and	NULL
was	NULL
unlikely	NULL
to	NULL
involve	NULL
other	NULL
mechanisms	NULL
such	NULL
as	NULL
squelching	NULL
or	NULL
titrating	NULL
a	NULL
repressor	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
results	NULL
indicate	NULL
that	NULL
transactivation	NULL
by	NULL
NFAT-family	NULL
proteins	NULL
is	NULL
regulated	NULL
at	NULL
multiple	NULL
levels	NULL
.	NULL

The	NULL
strongly	NULL
conserved	NULL
DBDs	NULL
operate	NULL
even	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
intrinsic	NULL
TADs	NULL
to	NULL
mediate	NULL
transcription	NULL
via	NULL
cooperating	NULL
factors	NULL
recruited	NULL
to	NULL
composite	NULL
sites	NULL
.	NULL

The	NULL
minimal	NULL
187-amino	NULL
acid	NULL
DBD	NULL
suffices	NULL
for	NULL
this	NULL
effect	NULL
,	NULL
emphasizing	NULL
the	NULL
remarkable	NULL
specialization	NULL
of	NULL
NFAT	NULL
-family	NULL
proteins	NULL
for	NULL
cooperative	NULL
interactions	NULL
on	NULL
DNA	NULL
.	NULL

The	NULL
DBDs	NULL
of	NULL
GATA	NULL
and	NULL
MyoD1	NULL
are	NULL
sufficient	NULL
to	NULL
induce	NULL
cell	NULL
differentiation	NULL
(	NULL
35	NULL
,	NULL
36	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
use	NULL
of	NULL
DBDs	NULL
of	NULL
transcription	NULL
factors	NULL
as	NULL
docking	NULL
sites	NULL
for	NULL
recruiting	NULL
other	NULL
transactivating	NULL
factors	NULL
may	NULL
be	NULL
a	NULL
general	NULL
mechanism	NULL
of	NULL
transactivation	NULL
.	NULL

NFAT1	NULL
also	NULL
contains	NULL
two	NULL
intrinsic	NULL
TADs	NULL
that	NULL
are	NULL
not	NULL
conserved	NULL
within	NULL
the	NULL
NFAT	NULL
family	NULL
:	NULL
indeed	NULL
,	NULL
the	NULL
region	NULL
corresponding	NULL
to	NULL
the	NULL
COOH-terminal	NULL
TAD	NULL
of	NULL
NFAT1	NULL
is	NULL
missing	NULL
in	NULL
NFAT	NULL
'	NULL
c	NULL
and	NULL
in	NULL
the	NULL
shorter	NULL
isoforms	NULL
of	NULL
NFAT4	NULL
(	NULL
5-9	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
the	NULL
conserved	NULL
NHR	NULL
appears	NULL
to	NULL
repress	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
NH	NULL
,	NULL
-terminal	NULL
TAD	NULL
,	NULL
since	NULL
its	NULL
removal	NULL
greatly	NULL
enhances	NULL
transactivation	NULL
mediated	NULL
by	NULL
the	NULL
unique	NULL
NH-terminal	NULL
region	NULL
.	NULL

Our	NULL
results	NULL
are	NULL
consistent	NULL
with	NULL
the	NULL
hypothesis	NULL
that	NULL
the	NULL
NHR	NULL
of	NULL
NFAT1	NULL
controls	NULL
the	NULL
subcellular	NULL
localization	NULL
of	NULL
this	NULL
protein	NULL
,	NULL
which	NULL
is	NULL
known	NULL
to	NULL
be	NULL
regulated	NULL
by	NULL
a	NULL
calcium-and	NULL
calcineurin-dependent	NULL
pathway	NULL
(	NULL
10	NULL
)	NULL
.	NULL

Removal	NULL
of	NULL
the	NULL
NHR	NULL
or	NULL
the	NULL
entire	NULL
NH	NULL
,	NULL
-terminal	NULL
region	NULL
from	NULL
NFAT1	NULL
abrogates	NULL
its	NULL
regulated	NULL
subcellular	NULL
localization	NULL
in	NULL
resting	NULL
and	NULL
stimulated	NULL
T	NULL
cells	NULL
(	NULL
29	NULL
)	NULL
,	NULL
and	NULL
transactivation	NULL
by	NULL
the	NULL
truncated	NULL
protein	NULL
NFAT1AN	NULL
is	NULL
no	NULL
longer	NULL
sensitive	NULL
to	NULL
ionomycin	NULL
or	NULL
CsA	NULL
.	NULL

Despite	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
strong	NULL
nuclear	NULL
localization	NULL
signal	NULL
in	NULL
the	NULL
GAL4	NULL
DBD	NULL
,	NULL
GAL4	NULL
chimeras	NULL
containing	NULL
the	NULL
NHR	NULL
also	NULL
show	NULL
significant	NULL
responsiveness	NULL
to	NULL
ionomycin	NULL
and	NULL
CsA	NULL
.	NULL

One	NULL
hypothesis	NULL
is	NULL
that	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
NHR	NULL
alters	NULL
the	NULL
nuclear-to-cytoplasmic	NULL
ratio	NULL
of	NULL
these	NULL
GAL4	NULL
chimeric	NULL
proteins	NULL
in	NULL
a	NULL
calcineurin-dependent	NULL
manner	NULL
.	NULL

Alter-natively	NULL
,	NULL
calcineurin	NULL
may	NULL
regulate	NULL
the	NULL
ability	NULL
of	NULL
the	NULL
NHR	NULL
to	NULL
mask	NULL
the	NULL
transactivation	NULL
properties	NULL
of	NULL
the	NULL
strong	NULL
NH	NULL
,	NULL
-terminal	NULL
TAD	NULL
of	NULL
NFAT1	NULL
.	NULL

In	NULL
either	NULL
case	NULL
,	NULL
the	NULL
NHR	NULL
is	NULL
likely	NULL
to	NULL
be	NULL
a	NULL
major	NULL
target	NULL
for	NULL
calcineurin	NULL
within	NULL
NFAT1	NULL
,	NULL
and	NULL
in	NULL
fact	NULL
we	NULL
have	NULL
shown	NULL
that	NULL
fragments	NULL
containing	NULL
the	NULL
NHRs	NULL
of	NULL
both	NULL
NFAT1	NULL
and	NULL
NFAT	NULL
'	NULL
c	NULL
bind	NULL
calcineurin	NULL
directly	NULL
(	NULL
29	NULL
,	NULL
37	NULL
)	NULL
.	NULL

The	NULL
conserved	NULL
sequences	NULL
of	NULL
the	NULL
NHRs	NULL
of	NULL
NFAT-family	NULL
proteins	NULL
suggest	NULL
that	NULL
NHR	NULL
may	NULL
contribute	NULL
to	NULL
the	NULL
CsA-sensitive	NULL
response	NULL
to	NULL
ionomycin	NULL
stimulation	NULL
of	NULL
all	NULL
NFAT-family	NULL
members	NULL
,	NULL
and	NULL
the	NULL
variation	NULL
in	NULL
NHRs	NULL
of	NULL
NFAT	NULL
-family	NULL
proteins	NULL
could	NULL
account	NULL
for	NULL
their	NULL
different	NULL
behavior	NULL
in	NULL
resting	NULL
cells	NULL
.	NULL

Although	NULL
there	NULL
is	NULL
no	NULL
clearcut	NULL
conservation	NULL
of	NULL
sequence	NULL
,	NULL
the	NULL
NH-terminal	NULL
~100	NULL
residues	NULL
of	NULL
NFAT1	NULL
,	NULL
NFAT	NULL
3	NULL
,	NULL
and	NULL
NFAT4	NULL
are	NULL
each	NULL
rich	NULL
in	NULL
acidic	NULL
residues	NULL
and	NULL
proline	NULL
(	NULL
5-8	NULL
)	NULL
,	NULL
and	NULL
contain	NULL
acid	NULL
hydrophobic	NULL
patches	NULL
characteristic	NULL
of	NULL
acidic	NULL
TADs	NULL
(	NULL
8	NULL
,	NULL
38	NULL
,	NULL
39	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
NH	NULL
;	NULL
-terminal	NULL
region	NULL
of	NULL
NFATc	NULL
(	NULL
which	NULL
is	NULL
also	NULL
capable	NULL
of	NULL
transactivation	NULL
;	NULL
Luo	NULL
,	NULL
C.	NULL
,	NULL
unpublished	NULL
data	NULL
)	NULL
is	NULL
proline	NULL
rich	NULL
but	NULL
not	NULL
acidic	NULL
.	NULL

Thus	NULL
transactivation	NULL
by	NULL
the	NULL
different	NULL
NFAT	NULL
-family	NULL
proteins	NULL
may	NULL
be	NULL
mediated	NULL
by	NULL
distinct	NULL
interactions	NULL
of	NULL
the	NULL
different	NULL
TADs	NULL
with	NULL
coactivators	NULL
,	NULL
TATA	NULL
,	NULL
binding	NULL
protein-associated	NULL
factors	NULL
(	NULL
TAFs	NULL
)	NULL
,	NULL
and	NULL
other	NULL
components	NULL
of	NULL
the	NULL
basal	NULL
transcription	NULL
machinery	NULL
(	NULL
40	NULL
)	NULL
.	NULL

In	NULL
conjunction	NULL
with	NULL
the	NULL
distinct	NULL
site	NULL
preferences	NULL
of	NULL
NFAT	NULL
-family	NULL
proteins	NULL
(	NULL
7	NULL
,	NULL
9	NULL
)	NULL
and	NULL
the	NULL
diverse	NULL
sequences	NULL
and	NULL
arrangements	NULL
of	NULL
NFAT	NULL
sites	NULL
in	NULL
inducible	NULL
promoter/enhancer	NULL
regions	NULL
(	NULL
1	NULL
)	NULL
,	NULL
such	NULL
interactions	NULL
may	NULL
determine	NULL
the	NULL
cell-specific	NULL
expression	NULL
of	NULL
cytokine	NULL
genes	NULL
.	NULL

We	NULL
thank	NULL
Tina	NULL
M.	NULL
Badalian	NULL
for	NULL
excellent	NULL
technical	NULL
assistance	NULL
.	NULL

We	NULL
are	NULL
grateful	NULL
to	NULL
Drs	NULL
.	NULL

EK	NULL
.	NULL

Flemington	NULL
,	NULL
D.A	NULL
.	NULL

Cantrell	NULL
,	NULL
D.	NULL
McKean	NULL
,	NULL
and	NULL
M.	NULL
Tremblay	NULL
for	NULL
reagents	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
grants	NULL
CA-42471	NULL
,	NULL
GM-46227	NULL
,	NULL
and	NULL
PO1	NULL
AI-35297	NULL
(	NULL
to	NULL
A.	NULL
Rao	NULL
)	NULL
.	NULL

C.	NULL
Luo	NULL
was	NULL
a	NULL
recipient	NULL
of	NULL
a	NULL
Lady	NULL
Tata	NULL
Memorial	NULL
Trust	NULL
Fellowship	NULL
.	NULL

Address	NULL
correspondence	NULL
to	NULL
Dr.	NULL
Anjana	NULL
Rao	NULL
,	NULL
Center	NULL
for	NULL
Blood	NULL
Research	NULL
,	NULL
Harvard	NULL
Medical	NULL
School	NULL
,	NULL
200	NULL
Longwood	NULL
Ave.	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
02115	NULL
.	NULL

Received	NULL
for	NULL
publication	NULL
22	NULL
November	NULL
1995	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
25	NULL
April	NULL
1996	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Rao	NULL
,	NULL
A	NULL
.	NULL

1994	NULL
.	NULL

NF-ATp	NULL
:	NULL
a	NULL
transcription	NULL
factor	NULL
required	NULL
for	NULL
the	NULL
co-ordinate	NULL
induction	NULL
of	NULL
several	NULL
cytokine	NULL
genes	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
.	NULL

15:274-281	NULL
.	NULL

2	NULL
.	NULL

Crabtree	NULL
,	NULL
G.R	NULL
.	NULL

,	NULL
and	NULL
N.A	NULL
.	NULL

Clipstone	NULL
.	NULL

1994	NULL
.	NULL

Signal	NULL
transmission	NULL
between	NULL
the	NULL
plasma	NULL
membrane	NULL
and	NULL
nucleus	NULL
of	NULL
T-lym-phocytes	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

63:1045-1083	NULL
.	NULL

3	NULL
.	NULL

Jain	NULL
,	NULL
J.	NULL
,	NULL
C.	NULL
Loh	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
,	NULL
1995	NULL
.	NULL

Transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
interleukin	NULL
2	NULL
gene	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Immunol	NULL
.	NULL

7:333-342	NULL
.	NULL

4	NULL
.	NULL

McCaffrey	NULL
,	NULL
P.G	NULL
.	NULL

,	NULL
C.	NULL
Luo	NULL
,	NULL
TK	NULL
.	NULL

Kerppola	NULL
,	NULL
J.	NULL
Jain	NULL
,	NULL
TM	NULL
.	NULL

Badalian	NULL
,	NULL
A.M.	NULL
Ho	NULL
,	NULL
E.	NULL
Burgeon	NULL
,	NULL
W.S	NULL
.	NULL

Lane	NULL
,	NULL
J.	NULL
Lambert	NULL
,	NULL
T.	NULL
Curran	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1993	NULL
.	NULL

Isolation	NULL
of	NULL
the	NULL
cyclosporin	NULL
A-sensitive	NULL
T	NULL
cell	NULL
transcription	NULL
factor	NULL
NFATp	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

262:750-754	NULL
.	NULL

5	NULL
.	NULL

Northrop	NULL
,	NULL
J.P.	NULL
,	NULL
S.N	NULL
.	NULL

Ho	NULL
,	NULL
L.	NULL
Chen	NULL
,	NULL
DJ	NULL
.	NULL

Thomas	NULL
,	NULL
L.A.	NULL
Timmerman	NULL
,	NULL
G.P	NULL
.	NULL

Nolan	NULL
,	NULL
A.	NULL
Admon	NULL
,	NULL
and	NULL
G.R	NULL
.	NULL

Crabtree	NULL
.	NULL

1994	NULL
.	NULL

NF-AT	NULL
components	NULL
define	NULL
a	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
targeted	NULL
in	NULL
T-cell	NULL
activation	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

369:497-502	NULL
.	NULL

6	NULL
.	NULL

Masuda	NULL
,	NULL
E.	NULL
,	NULL
Y.	NULL
Naito	NULL
,	NULL
H.	NULL
Tokumitsu	NULL
,	NULL
D.	NULL
Campbell	NULL
,	NULL
F.	NULL
Saito	NULL
,	NULL
C.	NULL
Hannum	NULL
,	NULL
K.-L.	NULL
Arai	NULL
,	NULL
and	NULL
N.	NULL
Arai	NULL
.	NULL

1995	NULL
.	NULL

NFATx	NULL
:	NULL
a	NULL
novel	NULL
member	NULL
of	NULL
the	NULL
NFAT	NULL
family	NULL
that	NULL
is	NULL
predominantly	NULL
expressed	NULL
in	NULL
the	NULL
thymus	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15:2697-2706	NULL
.	NULL

7	NULL
.	NULL

Hoey	NULL
,	NULL
T.	NULL
,	NULL
Y.-L.	NULL
Sun	NULL
,	NULL
K.	NULL
Williamson	NULL
,	NULL
and	NULL
X.	NULL
Xu	NULL
.	NULL

1995	NULL
.	NULL

Isolation	NULL
of	NULL
two	NULL
new	NULL
members	NULL
of	NULL
the	NULL
NFAT	NULL
gene	NULL
family	NULL
and	NULL
functional	NULL
characterization	NULL
of	NULL
the	NULL
NFAT	NULL
proteins	NULL
.	NULL

Immunity	NULL
.	NULL

2:461-472	NULL
.	NULL

8	NULL
.	NULL

Luo	NULL
,	NULL
C.	NULL
,	NULL
E.	NULL
Burgeon	NULL
,	NULL
J.A	NULL
.	NULL

Carew	NULL
,	NULL
T.M	NULL
.	NULL

Badalian	NULL
,	NULL
P.G	NULL
.	NULL

McCaffrey	NULL
,	NULL
W.S	NULL
.	NULL

Lane	NULL
,	NULL
P.G	NULL
.	NULL

Hogan	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1996	NULL
.	NULL

NFAT	NULL
1	NULL
(	NULL
NFATp	NULL
)	NULL
is	NULL
regulated	NULL
by	NULL
calcineurin	NULL
in	NULL
T	NULL
cells	NULL
and	NULL
mediates	NULL
the	NULL
transcription	NULL
of	NULL
several	NULL
cytokine	NULL
genes	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
,	NULL
Biol	NULL
.	NULL

16	NULL
:	NULL
In	NULL
press	NULL
.	NULL

9	NULL
.	NULL

Ho	NULL
,	NULL
S.N	NULL
.	NULL

,	NULL
DJ	NULL
.	NULL

Thomas	NULL
,	NULL
L.A.	NULL
Timmerman	NULL
,	NULL
X.	NULL
Li	NULL
,	NULL
U.	NULL
Francke	NULL
,	NULL
and	NULL
GR	NULL
.	NULL

Crabtree	NULL
.	NULL

1995	NULL
.	NULL

NFATc3	NULL
,	NULL
a	NULL
lymphoid-specific	NULL
NFATc	NULL
family	NULL
member	NULL
that	NULL
is	NULL
calcium-regulated	NULL
and	NULL
exhibits	NULL
distinct	NULL
DNA	NULL
binding	NULL
specificity	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:19898-19907	NULL
.	NULL

10	NULL
.	NULL

Shaw	NULL
,	NULL
K.T.-Y	NULL
.	NULL

,	NULL
A.M.	NULL
Ho	NULL
,	NULL
A.	NULL
Raghavan	NULL
,	NULL
J.	NULL
Kim	NULL
,	NULL
J.	NULL
Jain	NULL
,	NULL
J	NULL
.	NULL

Park	NULL
,	NULL
S.	NULL
Sharma	NULL
,	NULL
A.	NULL
Rao	NULL
,	NULL
and	NULL
P.G	NULL
.	NULL

Hogan	NULL
.	NULL

1995	NULL
.	NULL

Immunosuppressive	NULL
drugs	NULL
prevent	NULL
a	NULL
rapid	NULL
dephosphorylation	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
NFAT1	NULL
in	NULL
stimulated	NULL
immune	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

92:11205-11209	NULL
.	NULL

11	NULL
.	NULL

Ho	NULL
,	NULL
A.M.	NULL
,	NULL
J.	NULL
Jain	NULL
,	NULL
A.	NULL
Rao	NULL
,	NULL
and	NULL
P.G	NULL
.	NULL

Hogan	NULL
.	NULL

1994	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
NFAT	NULL
p	NULL
in	NULL
a	NULL
neuronal	NULL
cell	NULL
line	NULL
and	NULL
in	NULL
the	NULL
murine	NULL
nervous	NULL
system	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269:28181-28186	NULL
.	NULL

12	NULL
.	NULL

Wang	NULL
,	NULL
D.Z	NULL
.	NULL

,	NULL
P.G	NULL
.	NULL

McCaffrey	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
cy-closporin-sensitive	NULL
transcription	NULL
factor	NULL
NFAT	NULL
p	NULL
is	NULL
expressed	NULL
in	NULL
several	NULL
classes	NULL
of	NULL
cells	NULL
in	NULL
the	NULL
immune	NULL
system	NULL
.	NULL

Ann	NULL
.	NULL

NY	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

766:182-194	NULL
.	NULL

13	NULL
.	NULL

Mattila	NULL
,	NULL
P.S	NULL
.	NULL

,	NULL
K.S	NULL
.	NULL

Ullman	NULL
,	NULL
S.	NULL
Fiering	NULL
,	NULL
EA	NULL
.	NULL

Emmel	NULL
,	NULL
M.	NULL
Mc-Cutcheon	NULL
,	NULL
G.R	NULL
.	NULL

Crabtree	NULL
,	NULL
and	NULL
L.A.	NULL
Herzenberg	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
action	NULL
of	NULL
cyclosporin	NULL
A	NULL
and	NULL
FK506	NULL
suggest	NULL
a	NULL
novel	NULL
step	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
T	NULL
lymphocytes	NULL
.	NULL

EMBO	NULL
(	NULL
Eur	NULL
.	NULL

Mol	NULL
.	NULL

Biol	NULL
.	NULL

Organ	NULL
.	NULL
)	NULL

J	NULL
.	NULL

9:4425-4433	NULL
.	NULL

14	NULL
.	NULL

Brabletz	NULL
,	NULL
T.	NULL
,	NULL
I.	NULL
Pietrowski	NULL
,	NULL
and	NULL
E.	NULL
Serfling	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
immu-nosuppressives	NULL
FK506	NULL
and	NULL
cyclosporin	NULL
A	NULL
inhibit	NULL
the	NULL
generation	NULL
of	NULL
protein	NULL
factors	NULL
binding	NULL
to	NULL
the	NULL
two	NULL
purine	NULL
boxes	NULL
of	NULL
the	NULL
interleukin	NULL
2	NULL
enhancer	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

19:61-67	NULL
.	NULL

15	NULL
.	NULL

Yaseen	NULL
,	NULL
N.R	NULL
.	NULL

,	NULL
A.L	NULL
.	NULL

Maizel	NULL
,	NULL
F.	NULL
Wang	NULL
,	NULL
and	NULL
S.	NULL
Sharma	NULL
.	NULL

1993	NULL
.	NULL

Comparative	NULL
analysis	NULL
of	NULL
NFAT	NULL
(	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
)	NULL
complex	NULL
in	NULL
human	NULL
T	NULL
and	NULL
B	NULL
lymphocytes	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268:14285-14293	NULL
.	NULL

16	NULL
.	NULL

Choi	NULL
,	NULL
M.S.K	NULL
.	NULL

,	NULL
R.D	NULL
.	NULL

Brines	NULL
,	NULL
M.J.	NULL
Holman	NULL
,	NULL
and	NULL
G.G.B	NULL
.	NULL

Klaus	NULL
.	NULL

1994	NULL
.	NULL

Induction	NULL
of	NULL
NF-AT	NULL
in	NULL
normal	NULL
B	NULL
lymphocytes	NULL
by	NULL
anti-immunoglobulin	NULL
or	NULL
CD40	NULL
ligand	NULL
in	NULL
conjunction	NULL
with	NULL
IL-4	NULL
.	NULL

146	NULL
Mechanisms	NULL
of	NULL
Transactivation	NULL
by	NULL
Nuclear	NULL
Factor	NULL
of	NULL
Activated	NULL
T	NULL
Cells	NULL
17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

Immunity	NULL
.	NULL

1:179-187	NULL
.	NULL

Venkataraman	NULL
,	NULL
L.	NULL
,	NULL
D.A	NULL
.	NULL

Francis	NULL
,	NULL
Z.	NULL
Wang	NULL
,	NULL
J.	NULL
Liu	NULL
,	NULL
TL	NULL
.	NULL

Roth-stein	NULL
,	NULL
and	NULL
R.	NULL
Sen.	NULL
1994	NULL
.	NULL

Cyclosporin	NULL
A-sensitive	NULL
induction	NULL
of	NULL
NF-AT	NULL
in	NULL
murine	NULL
B	NULL
cells	NULL
.	NULL

Immunity	NULL
.	NULL

1:189-196	NULL
.	NULL

Prieschl	NULL
,	NULL
E.E	NULL
.	NULL

,	NULL
V.	NULL
Gouilleux-Gruart	NULL
,	NULL
C.	NULL
Walker	NULL
,	NULL
N.E	NULL
.	NULL

Harrer	NULL
,	NULL
and	NULL
T.	NULL
Baumruker	NULL
.	NULL

1995	NULL
.	NULL

A	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cell-like	NULL
transcription	NULL
factor	NULL
in	NULL
mast	NULL
cells	NULL
is	NULL
involved	NULL
in	NULL
IL-5	NULL
gene	NULL
regulation	NULL
after	NULL
IgE	NULL
plus	NULL
antigen	NULL
stimulation	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

154:6112-6119	NULL
.	NULL

Aramburu	NULL
,	NULL
J.	NULL
,	NULL
L.	NULL
Azzoni	NULL
,	NULL
A.	NULL
Rao	NULL
,	NULL
and	NULL
B.	NULL
Perussia	NULL
.	NULL

1995	NULL
.	NULL

Activation	NULL
and	NULL
expression	NULL
of	NULL
the	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
,	NULL
NFATp	NULL
and	NULL
NFATc	NULL
,	NULL
in	NULL
human	NULL
natural	NULL
killer	NULL
cells	NULL
:	NULL
regulation	NULL
upon	NULL
CD16	NULL
ligand	NULL
binding	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

182:801-810	NULL
.	NULL

20	NULL
.	NULL

Jain	NULL
,	NULL
J.	NULL
,	NULL
P.G	NULL
.	NULL

McCaffrey	NULL
,	NULL
V.E	NULL
.	NULL

Valge-Archer	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1992	NULL
.	NULL

Nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
contains	NULL
Fos	NULL
and	NULL
Jun	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

356:801-803	NULL
.	NULL

21	NULL
.	NULL

Jain	NULL
,	NULL
J.	NULL
,	NULL
P.G	NULL
.	NULL

McCaffrey	NULL
,	NULL
Z	NULL
.	NULL

Miner	NULL
,	NULL
TK	NULL
.	NULL

Kerppola	NULL
,	NULL
JN	NULL
.	NULL

Lam	NULL
bert	NULL
,	NULL
G.L	NULL
.	NULL

Verdine	NULL
,	NULL
T.	NULL
Curran	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
T-cell	NULL
transcription	NULL
factor	NULL
NFAT	NULL
p	NULL
is	NULL
a	NULL
substrate	NULL
for	NULL
calcineurin	NULL
and	NULL
interacts	NULL
with	NULL
Fos	NULL
and	NULL
Jun	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

365:352-355	NULL
.	NULL

22	NULL
.	NULL

Jain	NULL
,	NULL
J.	NULL
,	NULL
E.	NULL
Burgeon	NULL
,	NULL
TM	NULL
.	NULL

Badalian	NULL
,	NULL
P.G	NULL
.	NULL

Hogan	NULL
,	NULL
and	NULL
A	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

Rao	NULL
.	NULL

1995	NULL
.	NULL

A	NULL
similar	NULL
DNA-binding	NULL
motif	NULL
in	NULL
NFAT	NULL
family	NULL
proteins	NULL
and	NULL
the	NULL
Rel	NULL
homology	NULL
region	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
:	NULL
4138-4145	NULL
.	NULL

Yaseen	NULL
,	NULL
NR	NULL
.	NULL

,	NULL
J	NULL
.	NULL

Park	NULL
,	NULL
T.	NULL
Kerppola	NULL
,	NULL
T.	NULL
Curran	NULL
,	NULL
and	NULL
S.	NULL
Sharma	NULL
.	NULL

1994	NULL
.	NULL

A	NULL
central	NULL
role	NULL
for	NULL
Fos	NULL
in	NULL
human	NULL
B-	NULL
and	NULL
T-cell	NULL
NFAT	NULL
(	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
)	NULL
:	NULL
an	NULL
acidic	NULL
region	NULL
is	NULL
required	NULL
for	NULL
in	NULL
vitro	NULL
assembly	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:6886-6895	NULL
.	NULL

Northrop	NULL
,	NULL
J.P.	NULL
,	NULL
K.S	NULL
.	NULL

Ullman	NULL
,	NULL
and	NULL
G.R	NULL
.	NULL

Crabtree	NULL
.	NULL

1993	NULL
.	NULL

Characterization	NULL
of	NULL
the	NULL
nuclear	NULL
and	NULL
cytoplasmic	NULL
components	NULL
of	NULL
the	NULL
lymphoid-specific	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
(	NULL
NF-AT	NULL
)	NULL
complex	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268:2917-2923	NULL
.	NULL

Pfeuffer	NULL
,	NULL
I.	NULL
,	NULL
S.	NULL
Klein-Hebling	NULL
,	NULL
A.	NULL
Heinfling	NULL
,	NULL
S.	NULL
Chuyvpilo	NULL
,	NULL
C.	NULL
Escher	NULL
,	NULL
T.	NULL
Brabletz	NULL
,	NULL
B.	NULL
Hentsch	NULL
,	NULL
H.	NULL
Schwarzenbach	NULL
,	NULL
P.	NULL
Mat-thias	NULL
,	NULL
and	NULL
E.	NULL
Serfling	NULL
.	NULL

1994	NULL
.	NULL

Octamer	NULL
factors	NULL
exert	NULL
a	NULL
dual	NULL
effect	NULL
on	NULL
the	NULL
IL-2	NULL
and	NULL
II-4	NULL
promoters	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

153:5572-5585	NULL
.	NULL

Rooney	NULL
,	NULL
J.W	NULL
.	NULL

,	NULL
T.	NULL
Hoey	NULL
,	NULL
and	NULL
L.H	NULL
.	NULL

Glimcher	NULL
.	NULL

1995	NULL
.	NULL

Coordinate	NULL
and	NULL
cooperative	NULL
roles	NULL
for	NULL
NFAT	NULL
and	NULL
AP-1	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
murine	NULL
IL-4	NULL
gene	NULL
.	NULL

Immunity	NULL
.	NULL

2:473-483	NULL
.	NULL

Prieschl	NULL
,	NULL
E.E	NULL
.	NULL

,	NULL
G.G	NULL
.	NULL

Pend	NULL
]	NULL
,	NULL
N.E	NULL
.	NULL

Harrer	NULL
,	NULL
and	NULL
T.	NULL
Baumruker	NULL
.	NULL

1995.	NULL
p21	NULL
``	NULL
links	NULL
FceRI	NULL
to	NULL
NF-AT	NULL
family	NULL
member	NULL
in	NULL
mast	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

155:4963-4970	NULL
.	NULL

Flemington	NULL
,	NULL
EK	NULL
.	NULL

,	NULL
S.H	NULL
.	NULL

Speck	NULL
,	NULL
and	NULL
W.G	NULL
.	NULL

Kaelin	NULL
,	NULL
Jr.	NULL
1993	NULL
.	NULL

E2F-1-mediated	NULL
transactivation	NULL
is	NULL
inhibited	NULL
by	NULL
complex	NULL
formation	NULL
with	NULL
the	NULL
retinoblastoma	NULL
susceptibility	NULL
gene	NULL
product	NULL
.	NULL

147	NULL
Luo	NULL
et	NULL
al	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

90:6914-6918	NULL
.	NULL

Luo	NULL
,	NULL
C.	NULL
,	NULL
K.T.Y	NULL
.	NULL

Shaw	NULL
,	NULL
A.	NULL
Raghavan	NULL
,	NULL
J.	NULL
Aramburu	NULL
,	NULL
F.	NULL
Gar-cia-Cozar	NULL
,	NULL
B.A	NULL
.	NULL

Perrino	NULL
,	NULL
P.G	NULL
.	NULL

Hogan	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

Interaction	NULL
of	NULL
calcineurin	NULL
with	NULL
a	NULL
domain	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
NFAT1	NULL
that	NULL
controls	NULL
nuclear	NULL
import	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

USA	NULL
.	NULL

In	NULL
press	NULL
.	NULL

Lloyd	NULL
,	NULL
A.	NULL
,	NULL
N.	NULL
Yancheva	NULL
,	NULL
and	NULL
B.	NULL
Wasylyk	NULL
.	NULL

1994	NULL
.	NULL

Transformation	NULL
suppressor	NULL
activity	NULL
of	NULL
a	NULL
Jun	NULL
transcription	NULL
factor	NULL
lacking	NULL
its	NULL
activation	NULL
domain	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

352:635-638	NULL
.	NULL

Petrak	NULL
,	NULL
D.	NULL
,	NULL
S.A.	NULL
Memon	NULL
,	NULL
M.J.	NULL
Birrer	NULL
,	NULL
J.D	NULL
.	NULL

Ashwell	NULL
,	NULL
and	NULL
C.M	NULL
.	NULL

Zacharchuk	NULL
.	NULL

1994	NULL
.	NULL

Dominant	NULL
negative	NULL
mutant	NULL
of	NULL
c-Jun	NULL
inhibits	NULL
NF-AT	NULL
transcriptional	NULL
activity	NULL
and	NULL
prevents	NULL
IL-2	NULL
gene	NULL
transcription	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

153:2046-2051	NULL
.	NULL

Ghosh	NULL
,	NULL
G.	NULL
,	NULL
G.	NULL
Van	NULL
Duyne	NULL
,	NULL
S.	NULL
Ghosh	NULL
,	NULL
and	NULL
P.B	NULL
.	NULL

Sigler	NULL
.	NULL

1995	NULL
.	NULL

Structure	NULL
of	NULL
NF-KB	NULL
p50	NULL
homodimer	NULL
bound	NULL
to	NULL
a	NULL
«	NULL
B	NULL
site	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

373:303-310	NULL
.	NULL

Miller	NULL
,	NULL
C.W	NULL
.	NULL

,	NULL
F.A	NULL
.	NULL

Rey	NULL
,	NULL
M.	NULL
Sodeoka	NULL
,	NULL
G.L	NULL
.	NULL

Verdine	NULL
,	NULL
and	NULL
S.C.	NULL
Harrison	NULL
.	NULL

1995	NULL
.	NULL

Structure	NULL
of	NULL
the	NULL
NF-KB	NULL
p50	NULL
homodimer	NULL
bound	NULL
to	NULL
DNA	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

373:311-317	NULL
.	NULL

Boise	NULL
,	NULL
LH	NULL
.	NULL

,	NULL
B.	NULL
Petryniak	NULL
,	NULL
X.	NULL
Mao	NULL
,	NULL
C.H	NULL
.	NULL

June	NULL
,	NULL
C.-Y	NULL
.	NULL

Wang	NULL
,	NULL
T.	NULL
Lindsten	NULL
,	NULL
B.	NULL
Bravo	NULL
,	NULL
K.	NULL
Kovary	NULL
,	NULL
J.M	NULL
.	NULL

Leiden	NULL
,	NULL
and	NULL
C.B	NULL
.	NULL

Thompson	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
NFAT-1	NULL
DNA	NULL
binding	NULL
complex	NULL
in	NULL
activated	NULL
T	NULL
cells	NULL
contains	NULL
Fra-1	NULL
and	NULL
JunB	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13	NULL
:	NULL
1911-1919	NULL
.	NULL

Tapscott	NULL
,	NULL
S.J	NULL
.	NULL

,	NULL
RL	NULL
.	NULL

Davis	NULL
,	NULL
M.J.	NULL
Thayer	NULL
,	NULL
P.-F.	NULL
Cheng	NULL
,	NULL
H.	NULL
Weintraub	NULL
,	NULL
and	NULL
A.B	NULL
.	NULL

Lassar	NULL
.	NULL

1988	NULL
.	NULL

MyoD1	NULL
:	NULL
a	NULL
nuclear	NULL
phos-phoprotein	NULL
requiring	NULL
a	NULL
Myc	NULL
homology	NULL
region	NULL
to	NULL
convert	NULL
fi-broblasts	NULL
to	NULL
myoblasts	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

242:405-411	NULL
.	NULL

Visvader	NULL
,	NULL
J.E	NULL
.	NULL

,	NULL
M.	NULL
Crossley	NULL
,	NULL
J.	NULL
Hill	NULL
,	NULL
S.H	NULL
.	NULL

Orkin	NULL
,	NULL
and	NULL
J.M	NULL
.	NULL

Ad-ams	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
C-terminal	NULL
zinc	NULL
finger	NULL
of	NULL
GATA-1	NULL
or	NULL
GATA-2	NULL
is	NULL
sufficient	NULL
to	NULL
induce	NULL
megakaryocyte	NULL
differentiation	NULL
of	NULL
an	NULL
early	NULL
myeloid	NULL
cell	NULL
line	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15:634-641	NULL
.	NULL

Loh	NULL
,	NULL
C.	NULL
,	NULL
K.T.Y	NULL
.	NULL

Shaw	NULL
,	NULL
J.	NULL
Carew	NULL
,	NULL
J.P.B	NULL
.	NULL

Viola	NULL
,	NULL
C.	NULL
Luo	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1996	NULL
.	NULL

Calcineurin	NULL
binds	NULL
the	NULL
transcription	NULL
factor	NULL
NFAT1	NULL
and	NULL
reversibly	NULL
regulates	NULL
its	NULL
activity	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

In	NULL
press	NULL
.	NULL

Cress	NULL
,	NULL
W.D	NULL
.	NULL

,	NULL
and	NULL
S.J	NULL
.	NULL

Triezenberg	NULL
.	NULL

1991	NULL
.	NULL

Critical	NULL
structural	NULL
elements	NULL
of	NULL
the	NULL
VP16	NULL
transcriptional	NULL
activation	NULL
domain	NULL
.	NULL

Si-ence	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

251:87-90	NULL
.	NULL

Schmitz	NULL
,	NULL
ML	NULL
.	NULL

,	NULL
M.A	NULL
.	NULL

dos	NULL
Santos	NULL
Silva	NULL
,	NULL
H.	NULL
Altmann	NULL
,	NULL
M.	NULL
Czisch	NULL
,	NULL
TA	NULL
.	NULL

Holak	NULL
,	NULL
and	NULL
P.A	NULL
.	NULL

Baeuerle	NULL
.	NULL

1994	NULL
.	NULL

Structural	NULL
and	NULL
functional	NULL
analysis	NULL
of	NULL
the	NULL
NF-KB	NULL
p65	NULL
C	NULL
terminus	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269:25613-25620	NULL
.	NULL

Tjian	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
T.	NULL
Maniatis	NULL
.	NULL

1994	NULL
.	NULL

Transcriptional	NULL
activation	NULL
:	NULL
a	NULL
complex	NULL
puzzle	NULL
with	NULL
few	NULL
easy	NULL
pieces	NULL
.	NULL

Cell	NULL
.	NULL

77:5-8	NULL
.	NULL

